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S ummary
In the present study the mould Penicillium-cyclopium 
was chosen as a model system, with a view to exploring the 
possibility of selectively inhibiting the interconversion 
of its metabolites, orsellinic acid and penicillic acid.
This sequence necessitates a ring fission, involving cleavage 
of the bond linking carbon atoms 4 and 5 of orsellinic acid. 
This thesis is divided into three chapters:
1. A general introduction consisting of a survey of the back­
ground literature relating to the biosynthesis of penicillic 
acid.
2. This describes the syntheses of potential inhibitors 
including some derivatives of orsellinic acid. The established 
pathway for the preparation of orsellinic acid from ethyl 
acetoacetate and ethyl crotonate via bromination, hydrolysis 
and debromination is also evaluated, and the existing confusion 
in the literature concerning the bromination stage of this 
procedure is discussed.
3. This chapter is divided into two parts:
Part one concerns an investigation of various aspects of 
the course of the fermentation of P .c.yclopium and its relation­
ship to the biosynthesis of penicillic acid. In addition, the 
recovery of the culture filtrate metabolites 3-methoxy-2,5- 
toluquinol and the corresponding quinone is described.
Part two is devoted to a study of the feasibility of selec 
tively inhibiting penicillic acid biosynthesis, using stra­
tegically-designed derivatives of advanced intermediates such
5-chloroorsellinic acid. The inhibitory effect of low concen­
trations of this inhibitor was demonstrated through a series 
of feeding and autoradiographic experiments, which also led 
to the observation of the concomitant accumulation of other 
metabolites, two of which were shown to be precursors of 
penicillic acid.
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1.1 The nature of inhibition studies
Living cells are characterised by complex organised 
patterns of chemical reactions, which are catalysed and 
directed by highly integrated enzyme systems. These re­
actions provide the necessary energy for the various 
functions of the cell, and support the synthesis of mate­
rial upon which the cell depends for maintenance, growth 
and duplication. The metabolic activity of a living cell 
can be affected by many diverse environmental factors such 
as pH, X-ray irradiations, or high pressure. Since these 
factors have no specific role, it is difficult to use them 
to probe precise metabolic events. Studies of the effect 
of enzyme inhibition on cellular metabolism provide a 
more selective approach to the exploration of the nature 
of living material and its associated bio-transformations.
The introduction of a chemical substance into a cell, 
can cause distortion of the normal biosynthetic pathways, 
through the inhibition of selected enzymes, thereby block­
ing or diverting a main sequence into an alternative channel. 
The nature of inhibition processes can sometimes be ratio­
nalised in mechanistic terms, for example when an individual 
chemical substance specifically blocks a particular reaction 
or step in a metabolic sequence. It is sometimes possible 
to isolate the responsible enzyme or enzyme system in order 
to study the mechanism or interference. This can lead to a
more precise characterisation of the processes occurring 
within the cell in which the inhibitor exerts its effect. 
Metabolic inhibitors are often categorised as:
1. Competitive inhibitors. These combine reversibly with 
an enzyme at the same site as that involved in the forma­
tion of a normal enzyme-substrate complex. In this case, the 
degree of inhibition can be determined by the ratio of
the relative concentrations of the substrate and the com­
petitive inhibitor.
2. Non-competitive inhibitors. These bind irreversibly 
at the active site of an enzyme and may exhibit varying 
degrees of specificity. A selective inhibitor is one which 
blocks the action of an enzyme responsible for the catalysis 
of a specific individual step in a metabolic sequence.
3. Negative feed-back control of enzyme action. This effect 
is frequently observed and is a consequence of the ability
of a metabolic product to inhibit one or more st,eps in its 
own biosynthesis.
The present investigation has been directed to the 
design of potential selective inhibitors based on the pre­
paration of close structural analogues of essential inter­
mediates involved in secondary biosynthetic pathways with 
particular reference to penicillic acid. As part of an 
initial study of the feasibility of this approach,, the 
mould Penicillium c.yclopium was chosen as a model system,
with a view to exploring the possibility of selectively 
inhibiting the interconversion of its metabolites, orsel­
linic acid (1) and penicillic acid (2). This sequence 
necessitates a ring fission, involving cleavage of the 
bond joining carbon atoms 4 and 5 of orsellinic acid, as 
indicated in scheme 1.1. As will be described, it has 
proved possible to demonstrate that this process can be 
effectively blocked by introducing suitable substituents 
at either carbon.
CO^H
- CO
Orsellinic acid (1) Penicillic acid (2)
Scheme 1.1 C(4)-C(5) cleavage of orsellinic acid, leading to the
-  .. — —■■ ■■■■! ' i O
biosynthesis of penicillic acid.’ ( 0 = oxidative step, C1 =formate 
or methionine -derived methyl group and indicates C-C cleavage)
1 .2 The classification of primary and secondary metabolites
Primary metabolites may be defined as those metabolic 
products resulting from a series of interrelated enzyme- 
catalysed reactions, which provide the organism with its 
energy, synthetic intermediates and key macromolecules such
as proteins and DNA. They are basically the same for all 
living systems, whether plants, animals or microorganisms. 
Some examples of primary metabolites are amino acids, 
acetyl-coenzyme A, monosaccharides, mevalonic acid and 
nucleotides. On the other hand, secondary metabolites are 
the products of specialised biosynthetic pathways and are 
derived from primary metabolites (Table 1.1). These products 
have no obvious role in the economy of the corresponding 
organism. Secondary metabolites are found mostly in plants 
and microorganisms, and they have restricted taxonomic 
distribution.
Organic chemists have been responsible for the majority 
of studies of the structure and biosynthesis of those natural 
products categorised as secondary metabolites, which appear 
to express the individuality of species in chemical terms.
One of the earliest systematic studies of secondary
3
metabolites began with the work of Raistrick et al., who 
were particularly concerned with fungal products. The 
chemistry and biosynthesis of these compounds has been 
discussed in several reviews.^^
Table 1.1 Biosynthetic Classification of Secondary 
7
Metabolites.
Primary precursors 
Amino acids
Mevalonic acid
Glucose
Acetyl-CoA and 
propionyl-coA
C1 units (ex formate 
and methionine)
Secondary metabolites
Alkaloids, peptide derivatives 
(e.g. oligopeptides, diketopipera­
zines and penicillins), non-nitro- 
genous products (e.g. cinnamic acid 
derivatives).
Terpenes, sterols, carotenoids and 
general polyisoprenoids.
Glycosides, modified sugars (e.g. 
kojic acid) and oligosaccharides 
(e.g. streptomycin).
Polyketides: fatty acid derivatives 
polyacetylenes, and numerous phenols.
-OMe, -SMe, "NMe, -^CMe, ~CCH2OH 
groups, etc.
1.3 Polyketides
These are a large group of natural products, which are 
related to each other by their common biogenetic origins.
A polyketide is a general term, which was first used by
g
Collie , to describe compounds derived from poly-yS-keto 
intermediates. They include fatty acids, polyacetylenes 
and cyclic compounds which are mostly aromatic. These latter ' 
include mono and polycyclic phenols, e.g. orsellinic acid
and the tetracycline antibiotics. Fatty acids are found in
9
all organisms, and Shaw has compiled a list of the fatty
acids of fungi. Polyacetylenes are obtained from plants
and fungi, and consist of linear carbon chains containing
conjugated acetylenic or acetylenic-ethylenic systems, which
show a structural resemblance to fatty acids. The biosynthesis
10 11 12of the polyacetylenes has been frequently reviewed. 9 9
Aromatic polyketides, which comprise a major group of the
polyketides, are produced by microorganisms and higher plants.
Simple phenolic polyketides include 6-methyl salicyclic acid
(3) and gentisic acid (4), which have been isolated from the
culture filtrates of Penicillium griseofulvum.^
Recognition of the biogenetic origin of aromatic polyke-
5 16tides is primarily due to the work of Birch ’ who carried 
out an extensive series of tracer incorporation experiments.
COOH COOH
CH OH ..OH
HO
6-Methylsalicylic acid (3) Gentisic acid (4)
17On the basis of an earlier observation of Oppenheim
in which orcinol (5) was formed on heating "dehydracetic
8 18acid^ (6) with baryta, Collie 9 noted that treatment of
dehydracetic acid with hot concentrated sodium hydroxide
also gave compound (5). He also found that dehydracetic acid
with hot concentrated hydrochloric acid produced 2,6-di-
methy1-4-pyrone (7). The latter compound can be transformed
into diacetylacetone (8), which also gives orcinol in acidic
or strongly basic solutions (Scheme 1.2). Furthermore the
conversion of appropriate pyrones to secondary metabolites
19such as orsellinic acid have also been studied.
20 15Nearly thirty years ago Robinson and Birch indepen­
dently recalled Collie's work and suggested that phenols could 
be obtained by head-to-tail condensation of acetate units. 
Robinson's hypothesis suggested that orsellinic acidCT) could 
be produced from a unit corresponding to acetoacetic acid 
(9); Scheme 1.3.
CO-CH
Orcinol (5)
H C 0
^ Dehydracetic acid (6)
HC1
0
CH„ -00 -CH0-CO -CH0 -CO -CH_ 3 2 2 3
Diacetylacetone (8)
'Ba(OH)
2,6-Dimethyl~4-pyrone (7)
8 18Scheme 1.2 Alternative synthetic routes to orcinol (Collie 1 ).
CH.
.00 G0qh
ch2 CH2 C02H
C02H C-0
H„C3 (9) (1)
Scheme 1.3 Robinson’s hypothesis for the biosynthesis of
20orsellinic acid (1) .
1,3.1 Biosynthesis of polyketides
15Birch and Donovan showed that the correlation of the
structures of some natural products, for example, those
containing orcinol or phloroglucinol nuclei, supports the
hypothesis that these molecules are elaborated, at least in
part, by the head-to-tail linkage of acetate units. Birch
has confirmed his general hypothesis through a number of 
1 4C-acetate incorporation experiments, such as those which
established the biosynthesis of palitantin (10), and cyclo-
21paldic acid (11) (from P.cyclopium) , 6-methyl salicyclic
0 0 9 7
acid (3) and griseofulvin (13) (from P.griseofulvum). *
can undergo intramolecular cyclisation via aldol condensation 
or Claisen condensation. Aldol condensation leads to the 
production of substituted orcinols, whereas Claisen condensa­
tion yields aphloroglucinol (12), as follows:
0 OMe
Me COOH
CHO
Palitantin (10) Cyclopaldic acid (11)
2 4-
Birch also suggested that a ft -polyketo acid chain
CO CH CH0 - COSCoACO COCH
Aldol condensatio i--- -- 1
Claisen condensation
i
OH
Me
OH
0
11
Me-C
HO'
Orsellinic acid (1) Acetophloroglucinol (12)
As indicated in Scheme 1.4, a polyketide chain containing 8
or more carbon atoms can undergo reduction and dehydration
reactions to form a variety of phenolic products. The acetate
hypothesis received further support from early . studies by 
25 — 28Thomas , demonstrating that seven acetate units are 
involved in the biosynthesis of palitantin (10), alternariol 
(14) (Scheme 1.5) and the phenalenone nucleus of norherquei- 
none (17).
C-acylation 
(C-1 & C-6)
R-COOH + 3CH,-COOH
3H20
7 6 5 4 3 2 1
R-CO-CH -CO-CH2-CO-CK2-COOH
Aldol condensation 
(C—2 & c -1 )
Reduction at C-5
7 6 5 4 3 2 1
r-co-ch2-ch=ch-co-ch2-ccoh
C-acylation 
(C-1 & C-6)
Aldol conden 
tion (C-2
COR HOr£
CO„H
COR
CO^H
Scheme 1.A Biosynthesis of modified phenolic polyketides, 
R = CH^- or other suitable group e.g. C^H^-CH=CH-
Since the fatty acids are biogenetically related to 
many phenolic polyketides, a brief discussion of their bio­
synthetic pathway is relevant. From the discovery of/?-oxida­
tion of fatty acids until 1958, it was thought that fatty 
acids could be derived from acetate units by the reverse of 
the degradative pathway involving^-oxidation breakdown. In
1959, Lynen suggested that malonyl coenzyme A might be a key
29intermediate in fatty acid biosynthesis. Malonyl-coenzyme A 
was first obtained in the course of studies of yeast enzymes.
30
O 
0)
- 12 -
0COOH
MeO
0 Me
Cl Me 1
7 Me-COOH
HO
OH
HO Me
(H)
Scheme 1 .5 Head-to-tail linkage of seven acetate units leading 
'to the formation of alternarioK I4 ) and griseofulvin(l 3 ).
32Lynen also found that acetyl-coenzyme A serves as the 
primer of the process and that its C2 unit is only incorpo­
rated into the carbon-methyl moiety of the fatty acid produced.
33Tanenbaum and Bassett in their studies of the biosynthesis 
of 6-methyl salicylic acid, showed that the acetate and 
malonate precursors are incorporated as their CoA esters.
They also observed that in the absence of added malonate 
bio tin-dependent carboxylation of acetyl-co enzyme A to malonyl- 
coenzyme A takes place.
34Gatenbeck and Mosbach provided further evidence for
the involvement of a -polyketo acid-type intermediate in
the biosynthesis of orsellinic acid. They introduced 
1 8O-labelled sodium acetate to growing cultures of Chaetomium
cochliodes and observed radioactive orsellinicacid (1) with 
180 in both hydroxyl and carboxyl groups (Scheme 1.6).
4 Me-C1802H  4 MeC180SCoA  > MeC180-(CH2“C180)2~CH2-C180
Me
C 00H
8,0
18Scheme 1.6 Biosynthesis of orsellinic acid from O-labelled 
acetate.
Enzymes capable of decarboxylating malonyl-coenzyme A
to acetyPcoenzyme A were extracted from cells of Pseudomonas
35species by Hayaishi. This reaction does not apparently 
occur in P.urticae, ^  or p.cyclopium,^ although it does 
seem to take place to a significant extent in other penicillia 
s p e c i e s . 4-0 £en-fciey and Keil in their study of P . cyclo- 
pium showed that acetate and malonate units, in the ratio 
of one to three, must be present for the biosynthesis of 
penicillic acid (2) via orsellinic acid (1) (Scheme 1.7).
CH^-COSCoA
3
+ CO,
biotin
CH0-COSCoA
i 2
G02H
+ 3 malonate
 >■
- 3 C0o
CH
HO
d)
O rsel l inic acid
o'
v -
MeO
-5
-®C-
H“C 6
D
C4
OH
0
P e n i c i l l i c  acid ( 2 )
2
7 CH
G
ft=0
Scheme 1.7 Pathway of penicillic acid formation from one acetate
37and three malonate units (Bentley and Keil ) .
a acetate methyl © acetate carboxyl
n acetate methyl or malonate methylene 
€ acetate or malonate carboxyl
It has been shown that 6-methyl salicylic acid^'^
4-3 44orsellinic acid , and alternariol are in fact each
synthesised from one primer molecule of acetyl— -co enzyme A, 
the remaining carbon atoms being derived from malonyl-coen­
zyme A. These metabolites possess a C-methyl group which 
corresponds to the acetyl starter unit. It is generally 
considered that the cyclisation of a growing chain involves
a combination of Claisen and aldol condensations (path a,
28Scheme 1.9). Thomas , however, has suggested an alternative
mechanism (path b, Scheme 1.9) which could generate phenols 
without the mediation of ketonic intermediates. This involves 
the formation of an enzyme-stabilised poly- ^ -enolate (15)» 
with the appropriate geometry required to allow it to undergo 
an electrocyclic rearrangement to a carboxylic intermediate 
from which orsellinic acid is formed by a simple elimination 
process. The poly- ft -enolate mechanism is of particular 
interest in respect to the formation of polycyclic phenolics 
as illustrated by the possible derivation of phenalenones 
(based on 17) from the precyclisation intermediate (16) 
through a single concerted cyclisation step (Scheme 1.10).
The actual mode of cyclisation of any poly- $ -enolate, would 
be predetermined by the sequence of cis and trans double 
bonds, the formation of which may be dependent upon the 
stereospecificity of the elimination of the thioester group 
from the polyketide intermediates as shown in Scheme 1.8.
CO,I 2 - CO
Me  C * GHo -----
SR
"COSR
(b) R
-— > Me  q
cSR H,
COSR
MeC0CHoC0SR
OE GOSR
(D)
Me
cis-enolate
or
H,
\
C . =  <?-
HR
Me COSR
trans-enolate
Scheme 1.8 Possible stereo specificity of po.lyenolate formation.
Most of the acetate-derived phenolic metabolites inves­
tigated, belong to a family of compounds whose structures 
point to a one-chain-polyketo origin. There are however, 
a few compounds whose structures appear to be derived from 
two polyketo chains e.g. citromycetin (19). The result of the
chemical degradation of citromycetin (19) derived from
• / 14- x 4-5(2- C)-malonate, led G-atenbeck and Mosbach to suggest
that two acetate "starter" units are involved in the biosyn-
1 acetate + 3 malonate
path (aX
Me0
COSR
0 ,Me
COSR
0
\  path (h) 
OE
'COSR
¥
EO
OH
COSRMe
COOH
(a) via poly-/Mcetointermediates
(b) via poly-^-enolate intermediates
Scheme 1.9 Alternative pathways for the cyclisation of polyketides
0
OE JOH
IQE OE OE HOEO
OE
OEMe Me OH0 EMe
(17)
2 8Scheme 1.10 Cyclisation of the phenalenone precursor (Thomas ).
- 18 -
COOH
Scheme 1.11 Alternative biosynthetic pathways of citromycetin via
(a) a linear polyketide chain /(b) branched chain intermediate.
thesis of compound (19) as demonstrated in Scheme 1.11, path b).
Their findings apparently excluded the mediation of a linear 
polyketide-derived bicyclic intermediate such as (18) which 
could yield the carbon skeleton of citromycetin following 
C(10)—C(11) ring cleavage (Scheme 1.11, path a). Actually
Gatenbeck and Mosbach in their paper describing this work 
represented the hypothetical bicyclic quinone intermediate 
as (20) which they suggested could conceivably undergo conver­
sion to citromycetin (19) following C(2)-C(3) cleavage. . 
However,this particular cleavage sequence would not in fact 
lead to the carbon skeleton of citromycetin.
Me
HO
OH 0
(20)
As well as leading to the essential aromatic amino acids
the shikimic acid pathway also provides intermediates for
the biosynthesis of secondary metabolites. The biosynthesis
of shikimic acid (21) involves a series of reactions starting
with the condensation of erythrose-4-phosphate and phosphoenol
pyruvic acid (PEP) derived initially from glucose-6-phosphate.
Shikimic acid .is a key compound in the synthesis of the
C^-C, unit.6 3
Glucose
PEP
0
CH,I
C  C02H
OH
Chorismic acid
OH
Shikimic acid (21)
HOOC.
OH
Prephenic acid
Aromatic amino acids, e.g.phenylalanine, 
tyrosine, and tryptophan.
Secondary metabolites, e.g. simple benzenoid 
derivatives and phenolic compounds.
The shikimic acid pathway appears to play a smaller 
part in the biosynthesis of the secondary metabolites of 
fungi and in particular is infrequently used by the fungi im* 
perfecti, which produce a wide range of aromatic compounds 
by the polyketide route. However, under conditions of ex­
cess of carbohydrate with insufficient nitrogen for its 
conversion to amino acids, the shikimic acid or some other
- 21 -
precursor of amino acids may be used in the synthesis of
A /T A*~l
miscellaneous aromatic metabolites . Crowden studied 
the metabolism of shikimate - derived aromatic compounds 
in Polyporus tumulosus, and obtained the most efficient 
incorporation of radioactivity into the phenol from ,^C-
AO
labelled glucose and shikimate, Bassett and Tanenbaum 
suggested that the biosynthesis of pyrogallol and para- 
hydro xybenzoic acid in P. patulum could occur either by 
the shikimic acid pathway or by condensation of acetate 
units.
Although the carbon atoms of glucose are indirectly 
incorporated into all fungal metabolites, a few secondary 
metabolites of fungi are known to incorporate the intact 
carbon skeleton of glucose, for example kojic acid^ (22),
HO
CH^OH
Kojic acid (22)
Mevalonic acid, which is the precursor of fungal 
terpenes and steroids, is derived from acetyl-coenzyme A.
It is metabolised with loss of the carbonyl group to iso- 
pentenyl pyrophosphate which is the branched chain precursor 
of the polyisoprenoids. This subject has frequently been 
reviewed5’50’51’52.
In view of the concern of this thesis with the selec­
tive inhibition of penicillic acid formation by derivatives 
of orsellinic acid, it is of interest to list some naturally 
occurring orsellinic acid derivatives (fig. 1.1), since some 
of these could conceivably serve as selective inhibitors, 
e.g. everninic acid ' (orsellinic acid 4-methyl ether).
Me Me Me
COOH
OHHO
Me
3-Methyl orsellinic 
acid
COOHMe
OHHO
5-Methyl orsellinic 
acid
COOMe
OHMeO
Sparassol
Me Me Me
COOEt
HO OH
Ethyl orsellinate
COOH
HO'
Orsellinic acid
COOH
OHMeO
Everninic acid
- 23 -
Me
2-Methyl orcinol
Me
COOH
OHMeO
Me
' Me
Rhizonic acid
OHHO
Me
COOH
OMeHO
Orsellinic acid-2' 
methyl ether
HO
OHHO
OMe
Orcinol Dihydro fumigatin
Rig. 1.1 Naturally —  occurring analogues of orsellinic acid.53
1*3.2 Biosynthesis of fatty acids and -secondary metabolites 
in cell-free systems
54- 55Wakil, Titchener and Gibson ’ found that a biotin-
dependent enzyme was involved in the biosynthesis of long-
chain fatty acids from acetate. The biotin enzyme, which
56was first purified by Wakil from avian liver, turned out 
to be an acetyl-coenzyme A carboxylase, forming malonyl- 
coenzyme A as shown in the following equation:
-  *4 -
CH-7-CO-SCoA + ATP + HCO^ -3--— 00C-CH^-CO-SCoA +5 5 •<----    ^ c
ADP + Pi
29Lynen also suggested that malonyl-coenzyme A might 
he involved in the synthesis of fatty acids. This process 
requires NADPH as a reducing agent and a proportionately 
smaller amount of acetyl-coenzyme A as the primer of the
57chain-forming sequence. Lynen, Hopper-Kessel and Eggerer 
suggested the following equation for the biosynthesis of 
fatty acids:
AcetylCoA + n malonyl-CoA + ■ 2n NADPH + 2n H+ ------ ^
CH,—t> CH^-CH, — CO-CoA + n CO2 + 2n NADP+ + n H^O +
50In 1960, Lynen found that the transformation of 
malonyl-coenzyme A into fatty acids is achieved through 
intermediates that are covalently bound to thiol groups 
of the fatty acid synthetase. He classified these into 
two different types: ’central’1 and ”peripheral” . Sub­
sequently Lynen suggested that the reactions are catalysed
by a ”multi-enzyme complex”.'*®
No cell-free enzyme preparations capable of synthesi­
sing secondary metabolites had been isolated, prior to 1960,
'Z *z
when Tanenbaum and Bassett found that treatment of the
mycelium of P. patulum with dilute ammonia yielded a crude
enzymic extract, which catalysed the incorporation of acetyl'
59coenzyme A into patulin. Light subsequently found that
nCoA
- 25 -
H,C-C0-CHo-C0~ S ^  3 I • c
•CH.
H, CO — S /3
Acetyl
transferase
Malonyl
transferase
2CoA -4-
COOH
H00C-CHo-C0- S
CH.
Condensing
enzyme
CO
HS
H0C
^ 0H"c
I I
HS.
CH0“ CO- S ^
^C°2
*C
I
HC CH9-CO-S ■
ClK 2 *■ P
H02C-CH^ -C0-- .S'
A CoA
°^C 3
HC
Malonyl-CoA
^ CH-xCH2C0~Sp'\ 
HS.'
H C-C0-CHo-C0-S 3 2 p\£
HS ^
Malonyl
transferase CMalonylCoA CoA
HjC-CO-CHo-JIO-S.'-CHo-^ 0s p >  p\e
- CO, HS
\ / CH3
I
HS.
CH CH CO — S '
H„0
\ / CH3
dehydratase
HS_
-NADPH, H, I
p\E ^ nadp* 2me CHo - CO— S /
E
H00C-CHo-C0-S I c condensingenzyme
CH-CO-CH0-CO-CH„-CO-S ' 3 2 2 c
— c
reductase HO ^H
Scheme 1.12 Hypothetical scheme for the synthesis of 6-methylsalicylic acid via
a multi-enzyme complex.^ °(S * peripheral thiol site, S «* central thiol site),p c
^1- ^ C  , 2-^ H^ ) acetate is incorporated into fatty acids 
and 6-methyl salicylic acid in a culture of P . griseoful v urn, 
by the same general condensation process.
Lynen and co-workers^9^  showed that in the absence 
of NADPH, a P. patulum enzyme preparation yields only 
triacetic acid lactone (23). Consequently in 6-methyl 
salicylic acid formation, reduction appears to occur at 
the triacetic acid level, prior to the final condensation 
with malonyl-coenzyme A.
OH
Me
Triacetic acid lactone (23)
Subsequently, cell free extracts capable of synthesi­
sing orsellinic acid^, and alternariol^*^ were prepared, 
both systems providing evidence of a multi-enzyme complex, 
as in fatty acid biosynthesis, thus in the biosynthetic 
pathway leading to orsellinic acid from acetyl-coenzyme A
and malonyl-coenzyme A, the following enzymes and proteins
62are involved ; transacylases, acyl carrier protein, a con­
densing enzyme, a cyclization enzyme and an hydrolase.
It has been shown that P. baarnense produces the fatty 
acid palmitic acid and the secondary metabolite orsellinic 
acid. Mosbach and Bavertaft found that the ratio between
palmitic acid and orsellinic acid is not constant, but varies 
with the concentration of nitrate in the growth medium.
A lack of nitrate was accompanied by an increased incorpo­
ration of radioactive acetate in palmitic acid. Whereas in 
the presence of nitrate an increased incorporation into 
orsellinic acid was observed. Furthermore, it was shown 
that NADPH has no role in the synthesis of this aromatic 
polyketide.
A cell-free extract of Alternaria alternata catalysed 
the formation of alternariol from one mole of acetyl-coenzyme A 
and six moles of malonyl-co enzyme A. Sjoland and Gatenbeck^ 
also found that propionyl-coenzyme A could be utilised in­
stead of acetyl-coenzyme A by this fungus to form the C-ethyl 
homologue of alternariol.
65Radioactive tracer studies by Peterson suggested that 
A. flavipes cultures are capable of introducing a Cj unit 
into an aromatic ring, as follows:
HO CH3 C1
4 CH„-COOH 
3
COOH
OH
CH
COOH
OH
OH
(24) Flavi in
Later Gatenbeck and co-workers isolated an enzyme 
system from A. flavipes which is responsible for C-methyla- 
tion of a metabolite in this culture, and they suggested 
that C-methylation occurs on a tetraacetic acid structure 
bound to a protein prior to cyclization of the polyketide, 
and that c-methylation of an aromatic nucleus is not in­
volved in the formation of compound (24).
1.4 Tetronic acids including penicillic acid
Tetronic acids, which include penicillic acid (2) are 
those compounds which are structurally related to the lac­
tone (25). It has been usual to regard that 4-methyl tetronic 
acid (26) as the parent compound of the naturally-occurring 
fungal tetronic acids^*^® which are listed in Pig. 1,2.
All of these acids were isolated from culture filtrates of
69 ‘Penicillium, or Aspergillus species. Clutterbuck et al„ .
found that P. charlesii produces 4-methyl tetronic acid (26),
carolic acid (27), carolinic acid (29), carlic acid (32) and
70carolosic acid (31). Bracken and Raistrick' isolated de­
hydro carolic acid (28) from the metabolism solution of P.
cinerascens, whereas terrestric acid (30) was isolated
71 72from P. terrestre . Ceiger and Huber reported that iso­
lation of ascorbic acid (34) from Aspergillus, v. Tieghen,
73while Ramakrishnam described it as a metabolite of A. tamorii 
kita. Viridicatic acid (ethyl carlo sic acid) (33) was found
ry j
to be present in culture filtrates of P„ viridicatum .
_ 29 -
HO R,
(25)
R. R,
(26) 4-Methyl tetronic acid Me H
(27) Carolic acid Me -CO-CH2-CH2-CH2OH
(28) Dehydrocarolic acid =ch2 -C0-CH2-CH2-CH20H
(29) Carolinic acid Me -C0~CH2-CH2-C02H
(30) Terrestric acid Me -C0-CH2-CH2-CH0H-C2H
(31) Carlosic acid -ch2-co2h -CO-CH2-CH2-CH5
(32) Carlic acid -CH2-C02H -CO-CH2-CH2-CH2OH
(33) Viridicatic acid -CH2-C02H -C0-(CH2),-Me
HO OH
CHo0H-CH0H
Ascorbic acid (39)
Me
MeO
CH,
|| OH 0
Penicillic acid (2)
Pig. 1.2 Some tetronic acids and structurally related compounds
75Turner considered the tetronic acids derivatives as
a class of fungal products, which are, at least formally 
prepared from the condensation of an acetate derived chain 
with an intermediate of the tricarboxylic acid cycle. In 
other words derivatives of tetronic acid typically arise 
by condensation of a carboxyl group of a C^.-dicarboxylic 
acid with oC -methylene group of a polyketide.
The tricarboxylic acid cycle (TCA cycle) provides the 
requisite dicarboxylic acid and subsequently amino acids 
which can lead to the formation of the corresponding tetramic 
acids c f. tenuazonic acid, derived from isoleucine and 
acetoacetate.
tracer and chemical degradation experiments, which suggested
one molecule of acetyl-coenzyme A, two of malonyl-coenzyme A 
and a C^-carboxylic acid such as succinate. These results 
were obtained in the course of a study in which they found 
that labelled acetic acid is incorporated by P. charlesii 
into carolic acid (27) at positions 1,2 ,5 ,&7and 8, whereas
HOs.______ ^  COMe
Me
CH
Me —  C H ^ H
Tenuazonic acid 
(ex. Alternaria alternata )
77Bentley etal. obtained evidence from radioactive
that carolic acid could be derived from the condensation of
labelled malonic acids furnished only carbons 1,2,5 and 6 . 
They also found evidence that glucose metabolism in this 
fungus, may involve the hexose monophosphate pathway in 
the initial stages, and therefore suggested the following 
biosynthetic pathway for tetronic acid production, (Scheme 
1.13).
Penicillic acid
Penicillic acid (2) is a secondary metabolite, which, 
is produced by a variety of fungi, particularly species of 
the genus Penicillium. Penicillic acid was first isolated
n o
in 1910 by Alsberg and Black from the cultures of P. pube-
rulum. This fungus was grown either on a natural medium
such as corn meal mash, or on a chemically-defined medium
79such as Raulin-Thom .
Penicillic acid is toxic to mammals and has been shown
80 7 P>to be carcinogenic in rats . Alsberg and Black' found that
penicillic was lethal to mice on subcutaneous injection of
200-300mg/kg. The minimal lethal dose for rabbits ranged
81from 100-200mg/kg . Its antimicrobial activity was des­
cribed by Oxford et al. ^ * ^  , and Ciegler et al.^  inden- 
tified the products formed by the reaction between cysteine 
and glutathione with penicillic acid. Generally, penicillic 
acid can react with free-SH groups of the above mentioned 
amino acids (Scheme 1.14). It also inhibits alcohol dehy-
COOH
I
H00C-CHo-C-H 
2 I 
OH
CHo-C00H
I 2
CO
I
SCoA
HO-C
-» HOOC-CH0-CH .
2 0
CH
I
c=o
malonyl-
CoA
Malate
Acetyl-CoA C0-CHo-CH -CH
Malonyl-CoA S CoA
C-C0-CHo-CHo-CH,HO-C
H00C-CHo-CH c=o
~ hydroxylationCarlosic acid •— ------------a
Decarboxy- 
k lation
HO-C CH
H,C-CH C=0 
3
L-V -Methyl- 
tetronic acid
Carlic acid
decarboxylation
3 2 5 6 7 8
HO-C = C - C 0 - C H o-CH9-CHo0H
9 I, 1 I • 2 2 2
CH3-C<o'C=0
H
Carolic acid (27)
Scheme 1.13 Possible biosynthetic pathways for the formation 
of tetronic acids from the C^-dicarboxylic acid, malic acid.
drogenase at 1.1x10 M^, non-competitively, and lactic-
-5 85dehydrogenase at 7.2x10 M, competitively. Additional
details of the toxicity of penicillic acid are given in a
review hy Wilson.^
MeO
Me
h 2c
+ RSH
0
s\ Me
0
OH
MeO.
CH-
CH,
5h 0
"0
Scheme 1.14 Reaction between penicillic acid and RSH when RSH 
is cysteine or glutathione.^
1.4.1 Chemistry and natural occurrence of penicillic acid
on
Birkinshaw et al. following chemical degradation 
studies proposed the structure of penicillic acid as a mix­
ture of 4-keto-3-methoxy-5‘-methylene-hexa-2~enoic acid (35) 
and the corresponding %  -hydroxy lactone (2).
A summary of the chemical reactions of penicillic acid 
is given in Scheme 1.15.
On the basis of spectrophotometric investigations of
88 80penicillic acid and its derivatives, Shaw and Ford showed
that penicillic acid exists solely in the lactone form (2)
CH3 ° \
H3C\  6 
h 2c
CH
OH
(2)
OCH 
I 3
C —  C =  CH~COOH 
8
(35)
Kuhn-
Roth
HCHO(1) Pd+H
(2) CrO,
7 6
H3CX
7
H„C5
CH- C02H
BaJo.
7
BaCO BaCO
CH
CH^OH (as p-nitro- 
benzoate)
BaCO
(1) AcOH + Pb02 
(2) Acid hydrol.
CH
HC C - C
6
"CH.
°6H5 ~ N
N
NalO
2
BaCO
3
250°C
C6H5
5
HC
N
7
CH, .
I 3 1
■C ~ C
6
N
2
COOH 3
CHI.
Scheme 1.15 Chemical degradation of penicillic acid?^
in neutral aqueous solution. In 0.1N alkali, however, 
the ionic form corresponds to the ring-open structure (35).
Penicillic acid was first synthesised in 1948 by 
Raphael^ starting from the lactone (36) as shown in 
Scheme 1.16.
Natural occurrence
91Penicillic acid has been found in mouldy tobacco ,
92 93corn and beans . Ciegler and Kurtzman found that
P. martensii, P. palitans, P. cyclopium and P. puberulum 
were able to produce penicillic acid on various agricul­
tural commodities, although commodities with high protein 
contents did not support toxin synthesis. The extent of 
toxin production varied with the mould strain, the com­
modity, and the temperature; it was found that low tempera­
tures (1 to 10°C) favoured toxin accumulation. Lillehoj 
94et al. showed that an atmosphere enriched with 60% CO2 
(at 5°C and 10°C) reduced penicillic acid production below 
a detectable level, following inoculation of high moisture 
corn with P . martensii.
Penicillic acid is also produced in appreciable quan­
tities by fungi responsible for the blue-eye disease of 
93corn . Blue-eye is the name of a common storage disease
of this cereal crop involving several species of penicillia,
95e.g. P. martensii . This mould grows on high-moisture corn 
even at near-freezing temperatures.
0 CO s uccimmiQe 0
(36)
trimethylamine
Br
Me N - CH2 ~ CMe
OMe
I
C —  CH
CO
MeO
(1) heating with MgO
(2) acidification
Me
h 2c
\
O ' ^ ' o
OH
(87% yield)
Scheme 1.16 Raphael’s synthetic route for the preparation of 
penicillic acid.
The isolation of penicillic acid has been reported
96 96from the following fungi; P. lividum , P. griseum ,
97 87 97P. simplicissimum , P. c.yclopium , P . thomii ,
. ' 98 99
P. roqueforti (P. suavolens) , P.fennelliae t
P. aurantiovirens^ ^ , P. janthinellum1^ , P. viridicatum^^ ,
P. palitans102, P. baarnense 0^^, P. madriti1^ ,  P. lilacinum^ ^ ,
P. canescens10 ,^ P. chrysogenum^, P. olivinoviride^ ^ ,
a - •-n v, 107 a v. 108 . 109Aspergillus ochraceus , A. sulphureus , A. melleus ,
-i + • 1 1 0 . - , - , .  110 . . 110A. sclerotiorum , A. alliaceus , A. ostianus , and
96Paecilomyces ehrlichii .
Penicillic acid is not the only toxic compound pro-
111duced by P. cyclopium. Recently Bond et al. established 
the structure of two congeneric alkaloids, which were isolated 
from this fungus when grown on maize meal; these were desig­
nated cyclopiamine A (37) and B (38).
NO \\0Me
NO
(37) . (38)
1.4.2 Biosynthesis of penicillic acid
11 2Birch, Blance, and Smith showed that there is no 
apparent biosynthetic relationship between penicillic acid (2) 
and the terpenes, based on the negative result obtained on 
feeding (2~ 4C) mevalonic acid lactone to P. cyclopium. 
However, they found that GH^-^GO^H is readily incorporated 
into penicillic acid by the head to tail linkage of four 
acetate units, and suggested the following biosynthetic 
sequence (Scheme 1.17 Path a) involving orsellinic acid (1).
Me
(b)
OH
(1)
Me
I
a
MeO' CH
HOOG
Me
CH-C02H
co2h
MeO
Me \
H2c
OH
(2)
0
G — ' OMe
Scheme 1.17 Biosynthesis of penicillic acid via alternative
112ring cleavages; (a) 1,2 cleavage (Birch ), (b) 4,5 cleavage 
(Mosbach ).
1
Mosbach confirmed that orsellinic acid is converted
to penicillic acid by P. baarnense, but the results of
this tracer incorporation experiments indicated that the
cleavage of the aromatic ring occurs between positions 4
and 5 (Scheme 1.17, path b).
79 37Bentley and Keil ’ showed that labelled acetate, 
malonate and glucose are incorporated into penicillic acid 
in-P. cyclopium (Scheme 1.7; page 14)* From these experi­
ments, it was found that the C (6) and C (7) derive from 
acetate or glucose, but not from malonate. Malonate'was 
therefore not converted into acetate under their experi­
mental conditions and apparently represents a precursor 
beyond the acetate level. This chain is consistent with 
the derivation of penicillic acid from a single acetate- 
polymalonate, although no evidence was obtained for a 
pathway involving cleavage of an aromatic ring.
Cleavage of aromatic rings during the biosynthesis of
113secondary metabolites are not uncommon . Another example
of the field of acetate-malonate derived substances is the
fission of the ring of 6-methyl salicylic acid (3) to give
*1 "1 4-patulin (43) which occurs in P. patulum (Scheme 1.18).
115Tanenbaum and Bassett , who isolated various phenolic
compounds from this fungus, including gentisaldehyde (42)-,
116proposed pathway 'a1. Subsequently, Scott and Yalpani 
used deuterium-labelled precursors and mass spectroscopic 
analysis of the products fo study the biosynthesis of patulin 
(43). They found that m-cresol (39) is converted to compound
(43) and that deuterium from m-cresol is also incorporated 
into toluquinol (40) and gentisaldehyde (42), on the basis 
of which they proposed pathway !b ’ (Scheme 1.18).
I
CO CO
0 \
"CO CO (C-CO = CH3C02H)
CO^H CO^H COoH
CH OH
COOH
HOH C
CHO
(42)
CHO
h o h2c N jooh
0 " 'OH 
patulin
Scheme 1.18 Alternative schemes for the biosynthesis of patulin
[Tanenbaum and Bassett path a);Scott and Yalpani^& (path b)"] .
117Sekiguchi and Gaucher proposed a biosynthetic
route to patulin via in-cresol, m-hydroxybenzylalcohol,
m-hydroxybenzaldehyde , gentisaldehyde and phyllostine (44).
118More recently however, Sekiguchi isolated an isomer of 
patulin from P. urticae cultures, namely isopatulin (45), 
and by means of mutant studies showed that this compound 
is an intermediate in the biosynthesis of patulin. On the 
basis of these findings, it was suggested that a cleavage 
between C (4) and C (5) of phyllostine probably accounts 
for the biosynthesis of patulin.
0
H
HO
.0
H
0^ < H
Isopatulin
(45)
h o h2c
0 H
0
H
Phyllostine
(44)
H
H.
0 ,0
0
■ H 
OH
Patulin
(43)
Al-Rawi et al. have confirmed that cleavage of the 
aromatic ring occurs between C (4) and C (5) of orsellinic 
acid during the formation of penicillic acid. In this work,
•z
they fed ( H) acetate to a culture of P. cyclopium, and from 
3H-nmr spectra of the product directly determined the resulting
- -
labelling pattern, on the basis of which they proposed the 
following sequence for penicillic acid biosynthesis.
H„CO
OCH
OH
HO
HO
T
HO
T
OCH
OHOH
OCH
H
OH
119However, Axberg and Gatenbeck  ^subsequently suggested 
the following sequence for the biosynthesis of penicillic 
acid, which appears to require a reduction in the final stage
HO ■Me
COOH
OH
(1)
HO Me
COOH
OMe
(46)
HO'
OH
OMe
(47)
OMe
H
0 Me
OMe
(48)
Me
OH
OMe
2
This pathway was proposed on the basis of the in-
*1 A
corporation of (0 CH^-orsellinic acid-2-raethyl ether (46) 
and (O^CH^) -3-methoxytoluquinone (48) and the corres­
ponding quinol (47) into penicillic acid by P. cyclopium.
In the present study two P. cyclopium metabolites 
were isolated and identified as (47) and (48). It has 
also been established that cultivation of the fungus in 
the presence of 5-chloroorsellinic acid stimulates the 
accumulation of these compounds, while selectively inhi­
biting the formation of penicillic acid.
The mechanism of penicillic acid biosynthesis is fur 
ther discussed in Chapter 3 (pages 104-110).
“t J
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2.1 Introduction
Orsellinic acid is known to be an intermediate in the
biosynthetic pathway leading to penicillic acid in different
1112 104-fungi, such as P. c.yclopium 9 and P. madriti . An
attempt was made to examine what effect the addition of 
simple derivatives of orsellinic acid and structurally related 
compounds would have on the biosynthesis of penicillic acid.
Since orsellinic acid is not commercially available, it 
was prepared synthetically by a sequence involving conden­
sation of ethyl acetoacetate and ethyl erotonate to form ethyl 
dihydroorsellinate, with subsequent oxidative conversion to 
orsellinic acid via bromination, hydrolysis and debromination.
There is some confusion in the literature concerning the
1 20bromination step of this preparative method. Sonn and 
121
Santesson suggested that the bromination of ethyl dihydro­
orsellinate in glacial acetic acid produces ethyl dibromoorsel-
122 122 linate, while Kloss-Clayton and Gaucher-Shepherd claimed
that the bromination stage leads to the formation of ethyl di-
bromodihydroorsellinate. The present study shows that in this
synthetic procedure, bromination leads directly to the fully
aromatic product, as proposed by Sonn and Sante-sson. Prom the
analysis of the brominated compound its structure was confirmed
as ethyl dibromoorsellinate. Further more, it was found that
bromination of ethyl dihydroorsellinate (1:1 mole) with bromine
in glacial acetic acid and bromine water yielded a mixture of
ethyl orsellinate, ethyl monobromoorsellinate , and ethyl di-
bromoorsellinate in addition to some unchanged starting
material. It was also found that the aromatisation of ethyl
dihydroorsellinate could be carried out with sodium iodate
and potassium periodate in acidic media.
Standard procedures were used for the preparation of
some derivatives of orsellinic acid ( Table 2.11).
3In an isotopic synthesis, (3- H)-5-chloroorsellinic acid 
was prepared.from 5-chloroorsellinic acid according to the 
Pt/HTO- general tritium exchange procedure as utilised by 
Saljoughian^^ for the synthesis of (G-^H)-benzene.
2.2 Results and Discussion
The following synthetic approaches have been reported
for the preparation of orsellinic acid(6);
1 2 S(i) carboxylation of orcinol
i o 1 on
(ii) oxidation of protected orcylaldehyde *
(iii) condensation of ethyl acetoacetate (2) and ethyl 
crotonate (1) to form*ethyl dihydroorsellinate^Jwith sub­
sequent conversion to orsellinic acid via bromination, hydro­
lysis and debromination^^"’^ ^ .
Of the above methods, the last approach provided a
satisfactory source of orsellinic acid in reasonable yield.
123The preparative method described by Gaucher and Shepherd v 
(in 1971) was used in this work. They proposed the following 
sequence (Scheme 2.1), although as shown below this is only 
partially correct.
CH.
CH COOEt
HC
/
CHQ (a) Na/EtOH
h 3c ^ C ^ °
OEt
(1) (2)
W  h2so4
CH H 
H NX ^  COOEt
H
0 . '
'H
N0
H - ^ H
(3)
CH
COOEtBr
Bro/CH,C00H
>
Br
(4)
conc. H2S04
■>
CH, H 
Br >X T  COOH
/ 'H
0
Br H 
( 5)'
H2 (3atms.)
-5sv
5 % Pd/C
CH
COOH
HO OH
(6)
-j
Scheme 2.1 Synthesis of orsellinic acid(6)(Caucher and Shepherd
The condensation of ethyl acetoacetate (2) and ethyl 
crotonate (1) appears to involve the following stages;
(i) Michael condensation: this reaction is promoted by
sodium ethoxide, which generates the carbanion (7) from com­
pound (2) which in turn effects a nucleophilic attack at C(3) 
of ethyl crotonate (1) with formation of a carbon-carbon bond 
(Scheme 2.2).
(ii) Claisen condensation‘ by this process, the base catalyst 
(OEt) removes a proton from the methyl group at C(6) of com­
pound (8), and the resulting nucleophile then attacks the ester 
carbonyl at C(1) of compound (9).
The crystalline product of the condensation stage (com­
pound (3) ) on thin-layer chromatography (using chloroform 
—  acetic acid) showed only one spot (Rj-^ 0.34), showing it 
to be free of starting material.
The u.v. spectrum of this compound in ethanol showed a
peak at. X 282nm. (L=32300). This shifted to 255 nm whenmax
dilute hydrochloric acid was added, but on adding a slight 
excess of sodium hydroxide, the 282 nm peak reappeared.
This confirmed that ethyl dihydroorsellinate (3) exists in a 
ketonic form in dilute alcoholic solution ( cf. dihydroresor-
• i 128 xcmol ) .
The i.r. spectrum of this compound in nujol showed peaks 
at 1725cm  ^ (ester) and 1625cm  ^ due to 2,4-diketone (enolic)j 
Its melting point behaviour (87-890°) together with u.v. and 
i.r. spectral data indicated that it contains a mixture of 
keto and enol tautomers (Fig. 2.3).
H„C
3
0 H
II
C ^
CH
(2)
OEt
•C0oEt —C *s£-
H„C
3
0
EtO
0
■ II (7
x B
c. ^  
/ c
CH
H
(1)
H2C'
0
EtO
0
(I
c \
5 4CH
n1 o 3CH C \  I ^
H
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a
H
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COOEt
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C02Et
CH.
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0 
II
\ . c 
H^Cr 5
H 
[2°6
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4 CH
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^ C 1 3 CH
/  \ 2  /
^  C \
H H
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— CO 2^ t
—  Cfi,3
▼
*— C02Et
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Scheme 2.2 The condensation of ethyl acetoacetate and ethyl 
crotonate.
Fig. 2,3 Some possible keto-enol tautomers of ethyl dihydro­
orsellinate.
The identification of intermediates in the synthesis of 
orsellinic acid, was carried out as follows;
(1) Chromatography (Table 2.1).
(2) Microanalysis (Table 2.2).
(3) Mass spectroscopy (Table 2.3).
(4) H n.m.r. spectroscopy (Tables 2.4,2.5 and 2.6).
Table 2.1 Chromatographic comparison of intermediates in the 
synthesis of orsellinic acid.
Products (Scheme 2.1) Rj. (found) Rf (lit.)6
(4)* 0.86 0 .87
(5) 0.57 0 .59
(6) (orsellinic acid) 0.46 0.46
Solvent system; CHCl^ :glac. CH^CO^H (9:1v/v)
Silica gel plate; GF. 254,0.25mm.
* Products corresponding to the erroneous structures (4) and
Table 2.2: Microanalysis of orsellinic acid intermediates.
Products C°/o H°/o
Pound 33.85 2.77
(4) G10H12°4Br2 Req. 33.74 3.39
(14) C10H10°4Br2 Req. 33.92 2.85
Pound 29.37 1 .81
(5) C8H8°4Br2 Req. 29.30 2.46
(15) C8H6°4Br2 Req. 29.48 1 .85
Po und 52.03 5.17
(6) G8H8°4,H20 
(orsellinic acid)
Req. 51.61 5.41
C02R2
(6) Orsellinic acid R^=R2=H
(14) Ethyl dibromoorsellinate R^-Br 
and R2=Et
(15) Dibromoorsellinic acid R^=Br and
r2=h
Table 2.3 Mass spectral data of orsellinic acid intermediates.
Products M peaks (ip/e) Base peaks (m/e)
(14) 352,354,356 307,309,311
(1:2:1) (1:2:1)
(15) 324,326,328 280,282,284
(1:2:1) (1:2:1)
The characteristic triple peaks, M,M+2 and M+4 (due to
n  q g-j
Br and Br) and their relative intensities (1:2:1) indi­
cate the presence of two bromine atoms in the products (14) 
and (15). Base peaks in the above spectra resulted from 
the loss of OC2H^ from the product (14) and C02 from (15).
Table 2.4 H n.m.r. spectral data (CDCl^) of ethyl dibromo- 
orsellinate (14).
Chemical shift 
( $ P.p.m.)
No. of 
protons Assignment
1.37 3(tr,J=7.15Hz) C(1)-C0o-CHo-CH2 I I -d
2.6 3(s) C(6)-CH3
4.4 2(q• , J=6.95Hz) c (i)-c o2-ch2-ch3
*
6.4 1(br. s) -OH (probably C(4)-
( exchanged with hydroxy)
d 20)
Table 2.5 H n.m.r. spectrum (CDCl^) of dibromoorsellinic
acid (15).
Chemical shift No. of
(<£ p.p.m.) pro tons Assignment
2.7 3(B) C (6)~CH„
8.1 -8.75
( exchanged 1(br.s) -OH (probably C(4)-
with D20) hydroxy)
* This signal was assigned to the C(4)-0H since C(2)-0H
(not observed) would be expected to appear considerably down
129field due to H-bonding to the ortho carboxy C=0.
-j
Table 2.6 H n.m.r. spectral data (dg-acetone) of orsellinic 
acid (6) .
Chemical shift No. of protons Assignment
(£ p.p.m.)
2.45 3(s) C(6)-CH3
6.25 2( br. s) C(3) and G(5)-H
C(3) and C(5)-H signals appeared in 90MHz spectrum as 
doublets (at 6.29 and 6.23p.p.m. respectively; J ci 2.5Hz).
From the microanalytical, mass spectra and n.m.r. spectral
data which are listed in Tables 2.1 to 2.5, it becomes clear
that the intermediates in the second and third steps of this
preparative method (Scheme 2.1) have aromatic structure. These
experiments were carried out exactly as described by Gaucher
and Shepherd, and the melting points of the products of these
two steps were found to be the same as reported by these and 
120-122other authors. The intermediates in fact appear to
correspond to ethyl dibromoorsellinate (14) and dibromoorsellinic
120 121 acid (15), as previously suggested by Sonn and Santesson ,
although at the time of completing the present study we were
unaware of their publications. An alternative interpretation
of Sonn's reaction sequence was suggested by Kloss and Clayton
122 (Scheme 2.4, ,b l), however, this does not appear to be 
correct, since they claimed that ethyl 2,4-dibromo-5-niethyl-6- 
carboxyhexa-1,3-dione (4) ; was obtained by Sonn’s procedure, 
whereas Sonn correctly suggested the bromination of ethyl dihy­
droorsellinate in glacial acetic acid led directly to the
Br2/AcOH
40°C
H Me
C02Et
C02EtC02Et
•V
(3) MeH Me
Br
>
Br
(5)
H2,
Pd
Scheme 2.4 Alternative pathways (’a* and *b’) proposed for
the synthesis of orsellinic acid, [path 'a' suggested by
1 on 122
Sonn (1928) and path ’b f suggested by Kloss and Clayton
(1955)] .
ethyl dibromoorsellinate. Kloss and Clayton found that in the 
final step in Sonn’s procedure, i.e. the hydrolysis of ethyl 
orsellinate to orsellinic acid decarboxylation occurs upon 
acidification.
Since the bromination of ethyl dihydroorsellinate (3) 
led to the aromatisation of this compound, it was decided to 
investigate potential intermediates formed during this step. 
Compound (3) was treated with bromine in glacial acetic acid 
(1:1 mole). The following compounds were detected on thin-layer 
chromatography of the reaction mixture using a mixture of 
chloroform and acetic acid (9:1v/v): Compounds A (Rf=0.88) ?
B (Rf=0.69),C (Rf =0.57) and D (Rf=0.37).
Compounds A and D were identified as starting material 
and ethyl dibromoorsellinate. The purified compound B melted 
at 139-HO°C, its mass spectrum exhibiting two molecular ions 
Il/i: 274 and 276 (1:1) with base peaks appearing at
m/e 229 and 231 (1:1) due to ^ B r  and ^1Br isotopes. This 
indicates the presence of one bromine atom both in the molecular 
ion and the base peak. The molecular weight of this compound is 
the same as ethyl monobromoorsellinate (17), and the n.m.r. 
spectral data for compound B is consistent with this structure 
(Table 2.7).
Table 2.7 H n.m.r. spectrum of compound B (CDCl^).
Chemical shift 
(^ p.p.m.) No. of protons Assignment
1.37 3(tr. J=6.85Hz) c (i)-co2-ch2-ch
2.45 3(s) C(6)-CH,"5
4.37 2 (q. J=6.95Hz) c (i)-co2-ch2-ch.
5.9
(exchangeable 
with DgO)
1(br. s) C(4)-0H
6.4 1(s) C(3)-H
12.55
(exchangeable
l(br. s) C(2)-OH
with D2O)
The characteristics of compound C corresponded to
those of ethyl orsellinate (16),which structure was confirmed 
by comparison with an authentic sample (Tables 2.8 and 2.9).
Table 2.8 Some characteristics of compound C and ethyl orselli 
nate.
Compound m.p. M (m/e) Base peak Rf* V EtOH
(m/e) f Amax
C 131 -152 196
Ethyl 130-131°
orselli- (mixed 196
nate m.p. un­
depressed)
151(M-OEt) 0.57
151(M-OEt) 0.56
265
301
265
301
*
The mixture of CHCl^ and CH^COOH (9:1 v/v). was used as 
eluent.
By analogy with the mode of bromination of (3 -resorcylic 
130acid ; bromination of ethyl dihydroorsellinate (which is 
shown above to involve dehydrogenation) was considered most 
likely to yield 5-bromoethyl orsellinate (17). The u.v. 
spectrum of this compound showed two peaks at 296 (£=11139) 
and 260 (^=1879) in ethanol.
CH
HO OH
H
(16) Ethyl orsellinate R = H
(17) Ethyl 5-bromoorsellinate R = Br
1
Table 2.9 H n.m.r. spectral data of compound G and ethyl
orsellinate (CDC1,).
3
Chemical shift
Compound
No. of 
protons Assignment
1.4 3(tr, J=6.55Hz) C (1)-C-O-CH.-CH, il 2 -3
0
Ethyl * 
orsellinate
2.45
4.4
3(s)
2(q. ,J=6.75Hz)
C( 6) 
C( 1)
-CH,-5
-C-OCHa-CH, 
II -2 5 
0
6.2 2(s) C(3) and C(5)-H
' 1.37 
2.45
3(tr, J=6.95Hz) 
3(s)
C(1)
C(6)
-qf-'O-CHg-CH,
0'
-CH,-5
C <• 4.35 2(q. J=6.95Hz) 0(1) -C-0-CHo-CH„ 
il -2 3 
0
6.2
k
2 (s) C(3) and C(5)-H
Ethyl dihydroorsellinate'(3) was treated with bromine
water (1:1) and the main product was identified as ethyl
orsellinate. Compound (3) was also treated with iodine monobro- 
131 ‘
mide when the reaction yielded a mixture of ethyl orselli­
nate and ethylmonobromoorsellinate. The identification of 
these products was carried out by comparing their Rp values,
melting points and u.v. spectral data with those of authentic 
samples.
Further, the effect of the following reagents was inves­
tigated on the solution of ethyl dihydroorsellinate in acetic 
acid media; (i) KCIO^ (ii) KCIO^ (iii) Nal'O^  (iv) KIO^.
The ethereal extracts of the above mixtures on chromatography, 
indicated that only NalO^ and KIO^ yielded ethyl orsellinate. 
When these reactions were carried out at different pH values 
(i.e. 2,6 and 10), it was found that sodium iodate and potas­
sium periodate only react with ethyl dihydroorsellinate at 
pH 2.
The addition of bromine to the solution of
ethyl dihydroorsellinate in glacial acetic acid firstly 
produces ethyl orsellinate, the substitution reactions on 
the aromatic ring taking place on further reaction with 
bromine. The following scheme illustrates why the aromatisa- 
tion does not seem to occur in the debromination stage as
-j p *z 122
was suggested by Gaucher and Kloss.
-  -
Me H
OH
Br2/AcOH
Me
'OH
Me
OHHO
C02Et
** Orsellinic 
acid
(i) h 2so4
(ii) Haney Ni
3- or 5- bromo ethyl 
orsellinate (R  ^ or R2 Br]
Scheme 2>3 Probable bromination sequence for ethyl dihydro 
orsellinate (in preparation of orsellinic acid).
- On refluxing a number of hydroaromatic compounds with
D.D.Q (2 ,3-dichloro-5, 6-dicyano-1 ,4-benzoquinone) in benzene 
132 136aromatisation * has frequently been observed. An attempt
was therefore made to aromatise ethyl dihydroorsellinate by 
this method, but under the following conditions, only unchanged 
starting materials were recovered.
(I) 3:1 moles D.D.Q., 10hrs. reflux in benzene.
(II) 2:1 moles D.D.Q., 10hrs. reflux in benzene.
(III) 1:1 moles D.D.Q., 10hrs. reflux in benzene.
No brominated compounds were observed on thin-layer
chromatography, when ethyl dihydroorsellinate was treated
with ' NBS (N-bromosuccinamide) in the presence of a catalytic
amount of dibenzoyl peroxide under conditions which have been
successfully utilised for the bromination of 5-pentyl-3,4-*
133dihydropyran-2-one.
Dor the preparation of ethyl-5-bromo-6-methyl-1-car- 
boxyl-cyclohexa-2,4-dione (2,4) an attempt was made to obtain
the latter compound by condensation of ethyl acetoacetate 
and ethyl-o<-bromo crotonate. However, under similar condi­
tions to those used for the preparation of ethyl dihydro­
orsellinate a mixture of products resulted. Ethyl-oC -bromo
134crotonate was prepared according to the Moureu method, 
involving two stages starting from ethyl crotonate. Its 
n.m.r. spectrum corresponded to the required structure.
Table 2.10 N.m.r. spectral data for ethyl oL-bromo - crotonate.
Chemical shift ,T _ , . . .No. of protons Assignment
(<£p.p.m.)
1 .25
2.03 
4.17
6.7
3(tr., J=7.45Hz)
3(d., J=7.15Hz)
2(q. , J=7.15Hz)
1(q., J=7.75Hz)
-C-0-CHo-CH, 
il 2 .-3
0
CH^-CH^C-
-C-0-CHo-CH, 
I ~2 3
0
CH,-CH=C- .3 - i
- 64 -
In the present work an attempt was made to prepare
certain chloro derivatives of orsellinic acid (6) and
structurally related compounds. 5-Chloroorsellinic acid (19)
and 3-chloroorsellinic acid (20) were prepared according
121
to methods given hy Santesson. 2-Chloroorcinol (23) and •
5-chloro-ft -resorcylic acid (26) were prepared by chlorina­
tion of orcinol (27) and /S -resorcylic acid, in a similar 
manner to the preparation of 5-chloroorsellinic acid, using 
sulphuryl chloride. The structure of (23) was confirmed on 
comparing its melting point with the decarboxylation product, 
of 5-chloroorsellinic acid, while the structure of compound 
(26) was established through comparison of the melting point 
of its decarboxylated product with an authentic sample of
4-chlororesorcinol (28). The selectivity of the mono­
chlorination of the above mentioned compounds results from
the gradual release of free chlorine by sulphuryl chloride 
135in benzene, especially in the absence of a catalyst at
room temperature. The methylation of orsellinic acid and 
orcinol were also carried out by standard procedures.
[3-^Hj -5-chloroorsellinic acid (29) was prepared 
according to the method utilised for the synthesis of
•z 136
1G-- H ] -benzene. The specific activity of the product
(31.8 ^ Gi/mg) , recovered by preparative-tlc was sufficient
to permit the localisation of the aromatic tritium atom by 
■5
H-n.m.r. (Fig. 2.6). The tritium and corresponding proton ; 
resonances were very similar ($6.35 and 6.45p.p.m. respec­
tively) .
H n.m.r.
C-CH.
Acetone 
(solvent)
T
1
TTT
y 0235
00 H n.m.r.
10
Fig. 2.6 N.m.r. spectra (d^-acetone) of [,3-^ H j-5-chloro~
-]
orsellinic acid (a) H n.m.r. spectrum
(b) H n.m.r. spectrum 
showing exclusive triton-labelling at C-3 ( 6.45p.p.m.).
R
5
OH
Ri r 2 R3 R5 R4
(6) Orsellinic acid Me C02H H H H
(19) 5-Chloroorsellinic acid Me co2h H Cl H
(20) 3-Chloroorsellinic acid Me c o2h Cl H H
(21) 3,5-Dichloroorsellinic 
acid Me c o2h Cl Cl H
(22) Orsellinic acid-4-methyl 
ether Me co2h H H Me
(23) 2-Chloroorcinol Me H H Cl H
(24) 4-Chloroorcinol Me H Cl H H
(25) Orcino1-mono-methyl 
ether Me H H H Me
(26) 5-Chloro-/3-resorcylic 
acid H g o2h H Cl H
(27) Orcinol Me H H H H
(28) 4-Chloro-resocinol H H H Cl H
(29) [3-3H ] -5-Chloro-
orsellinic acid Me H 3h Cl H
Table 2.11 Synthesised potential inhibitors of penicillic 
acid.
2.3 Experimental
All the spectra obtained from the following instruments, 
except those mentioned in text;
(1) Perkin-Elmer n.m.r. spectrometer R-24A.
(2) Mass spectrometer M.S.12 .
(3) Unicam SP8000 U.V.Spectrophotometer.
(4) Perkin-Elmer IR-577.
1
« All the H n.m.r. spectra obtained in GDCl^, using T M  S 
as internal reference, except those which are mentioned in 
text.
1372.3.1 Preparation of anhydrous ethyl alcohol (c f. Yogel ).
Magnesium turnings (1.25g ) and iodine (0.25g ) were 
placed in a 500ml round bottomed flask. After adding absolute 
ethanol (18ml ), the flask was fitted with a double surface 
condenser, and a drying tube. The reaction mixture was then 
warmed until the iodine had disappeared, at which stage there was 
no sign of any hydrogen evolution. A further 250ml , of abso­
lute ethanol was added to the ethylated magnesium, and the 
mixture refluxed for 30 minutes. Then 150ml', of the alcohol 
was distilled off directly into a three-necked, round 
bottomed flask, which was used for subsequent experiments.
2.3.2 Preparation of ethyl dihydroorsellinate
To the flask containing super-dry ethanol (150ml...), 
equipped with a mechanical stirrer and a condenser, was added 
11.5g of sodium. The mixture was then warmed with stirring 
until the sodium has disappeared. Ethyl acetoacetate (65.1g ) 
was gradually added, followed by ethyl crotonate (57.1g ) 
and the reaction mixture refluxed with stirring until a thick 
cream-like slurry formed. At this stage, heating was stopped 
and the reaction mixture stirred for 3 hrs. It was then 
neutralised with 1M ^SO^. ( ^ e pH was adjusted to 7). The 
Na^SO^ was removed by vacuum filtration. The filtrate was 
diluted with distilled water (100ml ) and acidified (pH=4) 
with 6M HC1, prior to extraction with three 400ml. portions 
of chloroform. The combined chloroform extracts were again 
dried over anhydrous Na^SO^, and chloroform was then evapo­
rated under vacuum. Prom this 94.5g crude material was 
obtained, 2.0g of this compound was recrystallised from 
benzene and petroleum ether (40-60°C); recovery 80%, 
m.p. 87-89° (lit.123 88-90°).
2.3.3 Preparation of ethyl dibromoorsellinate
To a 11., 3-necked, flask containing 300ml of glacial 
acetic acid, 92.Og of the above mentioned crude material 
was added. The flask was then fitted with a mechanical 
stirrer and a condenser. When the compound had completely 
dissolved, 55 ml of bromine was gradually added to the
reaction mixture, and stirring was continued over night.
A white precipitate was then collected, washed with water, 
and dried (95.Og ). 1.Og of this product was recrystallised 
from ethanol (recovery 85.1%; m.p. 143-40, lit.^^143-4°).
2.3.4 Preparation of dibromoorsellinic acid
The crude product of the above (94.Og ) was dissolved in 
concentrated I^SO^ (300ml ) and was stirred for 1 hr. at 
room temperature. The solution was then transferred into a 
21. beaker half-filled with crushed ice, and a white precipi­
tate was obtained. The reaction mixture was subsequently 
extracted with two 800ml portions of diethyl ether, and the 
combined ethereal extracts were in turn extracted with three 
400ml portions of 0.5M NaHCO^. The combined sodium bicar­
bonate extracts were then immediately acidified with 6M HC1 
to pH=3, and the white solid formed was filtered, and dried 
(69.2g ; yield 80.6%). The crystallisation of this compound
in methyl.alcohol was not successful, unlike the result
122reported by Kloss and Clayton. It was however, recrys­
tallised (1.0g ) from glacial acetic acid-water; recovery 
72.6%, m.p. 213-214° (lit.125 212-213°).
2.3.5 Preparation of orsellinic acid
Debromination of the last product was carried out by 
the following methods.
(i) Using Pd on charcoal (5%) as catalyst;
Dibromoorsellinic acid (I6.0g )' was dissolved in glacial 
acetic acid (250ml ) and transferred to the hydrogenation 
instrument. To this solution, were added sodium acetate 
(8.0g ) and Pd/C (5%; 16.Og ), and the mixture was stirred 
under 3 atm. of hydrogen for 4 hrs. The reaction mixture 
was then filtered, and 500ml of distilled water was added 
to the filtrate. The solution was extracted with two 500ml, 
portions of ether. After washing the combined ethereal 
extracts with two 250ml of water, the ether phase was dried 
over anhydrous magnesium sulphate and then evaporated to 
dryness (4.1g ; Yield 48.5%).
(ii) The use of a nickel-aluminium alloy in an aqueous 
alkali.158
In a 500ml conical flask, dibromoorsellinic acid (8.3g ) 
was dissolved in 2M sodium hydroxide (200ml ) at 0°C. Then 
Raney*s nickel (8.0g ) was added, with stirring in small 
portions (in 1 hr. intervals), to the reaction mixture at 
below 4°C. After adding 0.5ml ethanol to the mixture, it 
was filtered into a flask containing cool conc. hydrochloric 
acid (70ml ). The filtrate was extracted with three portions 
of 500ml ether, and the combined extracts dried over anhy­
drous magnesium sulphate. The ether was then removed (3.7g ; 
yield 86%).
(iii) Debromination of dibromoorsellinic acid under 1 atm. Hg
(A) using Pd on 0 (5%), ( B.) using Pd on CaCO^i this catalyst
139
was prepared according to Busch and Stoves* method.
In both instances, after 6 hrs. of shaking the reaction 
mixture at room temperature, the yields obtained were less 
than 5%.
The crude products, in each method were recrystallised 
from a mixture of glacial acetic acid and distilled water.
The orsellinic acid was collected as white needle \ form 
crystals, which were dried in a vacuum oven'for 24 hrs., 
(recovery 75% and m.p. 175-176°C, lit.121 174-175°C).
2.3.6 Bromination of ethyl dih.ydroorsellinate (1 simple)
Ethyl dihydroorsellinate (5.94g ) was dissolved in gla­
cial acetic acid (20ml ) inside a 100ml , 3-necked, flask 
equipped with a magnetic stirrer and a condenser. To this 
solution, bromine (4.8g ) in acetic acid (20ml ) was gradually 
added within 3 hrs. with stirring at 40°G. The reaction mix­
ture was then poured into a 500ml. beaker which already
contained 200ml of 10% NaoC0_. This solution was then2 3
extracted with two 100ml portions of ether, and the combined 
ethereal extracts washed with four 100ml of water. After 
drying the ethereal extract over anhydrous magnesium sulphate, 
the solution was concentrated. Thin-layer chromatography, 
using CHC1^;CH^C00H (9:1 v/v ) as solvent system, showed that
it was a mixture of ethyl dibromoorsellinate, ethyl 5-bromo- 
orsellinate, ethyl orsellinate and the starting material.
The aromatic compounds were separated by column chromatography 
technique, using chloroform and ethyl acetate mixture (19:1 
v/v ) as eluent. The column was made up from silica gel 
120 mesh (height=150cm). Ethyl dibromoorsellinate was recrys­
tallised from a mixture of water-ethanol (0.91g , m.p. 143-4°; 
yield 8.5%). Ethyl monobromoorsellinate was recrystallised 
from water-acetic acid mixture and the crystals obtained 
were dried in a vacuum oven at 30°C for 2 days (2.79g , 
m.p. 139-140°; yield 33.2%). Ethyl orsellinate was recrys­
tallised by the same method as described for ethyl mono­
bromoorsellinate (2.10g , m.p. 131-2°; yield 35.1%).
2*3.7 Bromination of ethyl dihydroorsellinate with- ■bromine water 
To 10ml. solution of ethyl dihydrobromoorsellinate (2.0g j
in glacial acetic acid, 10ml of 10% bromine water was
- \
gradually added (in 1 hr.) with continuous stirring 
at room temperature. At this stage, the solvents were evapo­
rated and the residue obtained was washed \ 'with two 50ml u 
portions of water. The residue (1.35g ) was then recrys­
tallised from acetic acid-water mixture (0.98g., m.p. 131- 
132°C, R fd0.56 silica tic- CHCl^:CH^COOH = 9:1, its u.v. 
spectrum showed two maxima In ethanol at 265nm and 301nm ).
2.3.8 Bromination of ethyl dihydroorsellinate with iodine 
monobromide
131(i) Preparation of iodine monobromide . Finely divided iodine 
(2.6g ) in glacial acetic acid (6ml ) was treated with bromine 
(0.5ml ) at 50°0.
(ii) Iodine monobromide which was already prepared was gra­
dually added to ethyl dihydroorsellinate (4.0g ) solution in 
glacial acetic acid (10ml ) with stirring at 40°G. After
4 hrs. of stirring, the reaction mixture was filtered, 'the
filtrate was then treated with 100ml aqueous solution of
sodium bisulphite (1.6g ) and sodium bicarbonate (I6g).
After 12 hrs., the reaction mixture was filtered and the solid
washed with two 20ml portions of water, it was then dried
in a vacuum oven (30°C) for a period of 2 days(yield 2.51g).
Thin-layer chromatography using a CHC1,: CH,C00K'
5 5 -
mixture (9:1v/v) as solvent system, showed this to be, 
a mixture of ethyl orsellinate and ethyl-5-bromoorsellinate. 
Pure compounds were obtained from preparative chromatography 
(30mg of mixture was used) using the above mentioned solvent 
system on silica gel (GF 254, 0.5mm). [Ethylorsellinate; 
m.p. 131-132°C, Rr ^  0.56 , X 265 and 301.; Ethyl-5-
I IHclX
bromoorsellinate, m.p. 139-140°C, Rf ^0.68 , £ =11139)
and A  g0 ( & =1879) ] .
2.3.9 Effect of some oxidizing reagents on ethyl dihydro­
orsellinate
The following reagents were added to the five test tubes 
containing ethyl dihydroorsellinate (0.2g.) in acetic acid
(1ml );
(a) 1ml of saturated solution of KG 10,, 3 in water.
(b) 1ml of saturated solution of KC10 , 4
in water.
(c) 1ml of saturated solution of NalO, in water.
U) 1ml of saturated solution of k i o4 in water.
(e) 1ml of concentrated HCIO^.
These tubes were then placed in a water bath at 40°C. 
Thin-layer chromatography of ethereal extracts of the samples' 
(at varying times) indicated that only those which contained 
10^ and 10^ yielded ethyl orsellinate (Rf — 0.56) in 30 mins. 
In the case of 10^ and 10^ respectively 50 and 70 per cent
of the starting material had changed to ethyl orsellinate
after 24 hours.
In another experiment 1ml of a saturated solution of 
KIO^ in water was added to three test tubes containing 
2ml of alcoholic solution of ethyl dihydroorsellinate (0.2g.) 
After adjusting the pH in the following order, pH 2., pH 6 
and pH 10, the test tubes were then placed in a water bath
and the temperature was kept at 40°C. After 4 hrs. they were
extracted separately with two 5ml portions of ether in 
acidic medium (pH 2). The combined ethereal extract of each 
sample was evaporated under reduced pressure. Among these
residues only pH=2showed a spot at ethyl orsellinate z o n e  ' 
on thin-layer chromatogram. From preparative chromatography 
of this residue ethyl orsellinate was recovered (81 .5mS > 
m.p. 130-131°C, yield 41%).
2.3.10 Condensation of ethyl acetoacetate with cO-bro mo crotonate
Ethyl crotonate (27.Og ) was slowly treated by a solu­
tion of bromine (37.8g.), in glacial acetic acid (20ml ), 
with stirring at room temperature for 1.3 hrs. After adding 
formic acid (a few drops), the mixture was treated with a 
solution of 1M NaHCO^, and extracted with two 80ml. portions 
of ether. The combined ethereal extracts were evaporated under 
vacuum, and the remainder was refluxed with sodium acetate 
(9.0g ) in ethanol (150ml ) (in a dark place) for 4 hrs.
After removing NaBr and ethanol, the solution was mixed with 
40ml sodium' bicarbonate (5%) and extracted with two 50ml. 
portions of ether. The combined extracts were dried over 
Na^SO^, and ether was evaporated under vacuum (27.1g ).
Ethyl -bromo crotonate was treated with ethyl acetate 
under the same conditions as described for condensation of 
ethyl acetate and ethyl crotonate (p. 67 ). Under these
conditions no solid was separated,and the obtained solution 
on thin-layer chromatogram (using CHCl^:CH^COOH (9:1v/v)) 
showed seven spots.
2.3.11 Bromination of ethyl dihydroorsellinate. with NBS
Ethyl dihydroorsellinate (0.5g ) was dissolved in CCl^ 
(50ml ) and refluxed with N-bromo-succinimide (0.45g ) in 
the presence of dibenzoyl peroxide (0.15g ) under a mercury 
lamp (400w) • The mixture on chromatography plate showed only 
starting materials.
This procedure was repeated in benzene, and no product 
was obtained.
14.0 1 ? 12.3.12 Preparation of 5-chloroorsellinic acid. ’
Dry orsellinic acid (4.2g,recrystallised from benzene) . 
was dissolved in dry ether (100ml) in a 250ml. two necked, 
round bottomed flask, equipped with stirrer and a drying tube. 
This solution was treated at room temperature with sulphuryl 
chloride (3.375g ) in dry ether (20ml ). After 4 hrs. the 
reaction mixture was washed with two 30ml • portions of water, 
the ether was then evaporated under reduced pressure, and , 
the residue obtained was recrystallised from water. The 
crystals were dried in a vacuum oven at 30°C for 24 hrs.
3.09g., yield 61.33%, m.p. 196-197°C; lit.121 182.5-184°C. 
(recrystallised from benzene), Rp=i0.70J micro analytical 
and n.m.r spectral data are as follows:
Microanalytical data:
C°/o H%
Found 47.15 3.34
Calculated 47.42 3.47
N.ra.r. spectral data:
Signal position 
(S;P P m)
6.45
Ho. of protons Assignment
2.67
1 (s) 
3 (s) Ar-CH
Ar-H
3
Mass spectral data:
M+ peaks at m/js 204 and 202 (3:1 )
Base peaks at m/_e 160 and 158 (3:1)
2.3.13 Preparation of 3-chlor6orsellinic acid
This compound was prepared in three stages from orsellinie
. . 121 acid.
(A) 5-iodoorsellinic acid - A mixture of dry orsellinie acid 
(1.68g ) and iodine (2.5g ) in ether (50ml ) was treated with 
yellow mercuric oxide (2.1g ) in small portions. After 30 mins. 
refluxing , the reaction mixture was kept at room tempera­
ture for 2 hrs. The mixture was then filtered and the filtrate 
washed with 50ml. of aqueous KI (10%) and water (50ml ).
Ether was then removed and the residue obtained (2.48g , 
yield 84%) was recrystallised from benzene (recovery 88%, 
m.p. 172-173°C).
“ I O ~
(B) 5-Iodo-3-chloroorsellinic acid; 5-Iodoorsellinic acid
(2g ) in dry ether (60ml ) was treated with 3ml , of sulphury1 
chloride in ether (30ml ) and the reaction mixture was then 
stirred at room temperature. After 24 hrs. it was washed 
with five 100ml portions of water, and the ether was then 
removed. The residue obtained (1.42g ) was recrystallised from 
benzene (1.21g , 54%, m.p. 199-200°C).
(C) 3-Chloroorsellinic acid*. The above product (1.10g ) was 
dissolved in 35ml of 2M NaOH, and it was then treated with 
25~50mg. portions of Raney nickel alloy when the evolution 
of gas became rapid. At this stage, the solution was filtered 
into 7.0ml of conc. HC1, and the filtrate diluted with water 
(70ml ). This solution was extracted with three 100ml por­
tions of water. After removing ether, the residue was recrys-
10 1
tallised from benzene (0.57g , 83%, m.p. 173-174°C; lit. 
172-174°C, R^  — 0.70) microanalytical data:
C% H%
Found 47.30 3.37
Calculated 47.42 3.48
Table 2.12 H n.m.r. spectral data of 3-chloroorsellinic 
acid (dg-acetone).
Signal position No. of protons Assignment
6.46 1 (s) 
3 (s)
Ar-H
2.66 Ar-CH,—3
3
2.3.14 Preparation of [3- Hi -5-chloroorsellinic acid
The preparation was achieved in a similar way to the 
method used for [G-^h3-benzene, as reported by Saljoughian.1^ 4 
Since tritium is, a . ft -emitter a trial experiment was firstly 
carried out for preparation of [3-D ] -5 -chloroorsellinic acid.
Preparation of catalyst - Pt was prepared according to 
Calf’s method]41 In a 100ml beaker, 100mg of sodium borohydride 
was slowly added to a suspension of platinum oxide (40mg ) 
in 50ml of water. Hydrolysis of the excess sodium borohy­
dride was accomplished by warming the reaction mixture at 
70°C. The catalyst was collected, washed with water to • 
remove salts, and the water finally decanted.
5-Chloroorsellinic acid (8.2.mg ), in a small test tube, 
was dissolved in dioxane (0.2ml )’, Pt° and HTO (10^ 0. ,
50mCi/ml ) was then added to this solution. The reaction 
mixture was frozen, the tube evacuated from the air and 
sealed over a flame. The test tube was then heated in an oil 
bath at 110°C. After 18 hrs. the reaction mixture was filtered 
and the solid washed with six 2ml portions of acetone. The 
solution was then freeze-dried, and the residue obtained 
dissolved in methanol (2.5ml ) and the solution again freeze- 
dried (the process was repeated three times). Pure
•5
[3- Hj-5 -chloroorsellinic acid (5.495mg ) was then obtained 
from preparative chromatography using CHCl^ i,CH^ C00H (9:1v/v).
2.3.15 Preparation of 3,5-dichloroorsellinic acid
Dry orsellinie acid (0.42g ) in dry ether (40ml ) was 
treated at room temperature with sulphuryl chloride (1ml , 
1.485g ) in ether (4ml ).After 18 hrs. the reaction mixture 
was washed with two 15ml portions of water, the ethereal 
solution was then evaporated under vacuum,and the residue 
obtained recrystallised from benzene (0.513g , yield 87%, 
m.p. 187-188°C, R^-0.78). Its mass spectrum showed the 
M+ peaks at m/e 240,238 and 236 (8:5:1), the base peaks 
appeared at m/e 196,194 and 192 (8:5:1).
2.3.16 Mono-chlorination of orcinol
(A) Dry orcinol (1.24g ) in dry ether (100ml ) was treated 
at room temperature with sulphuryl chloride (1.35g*, 0.9ml.) 
in dry ether (10ml ). The reaction mixture was stirred for 
4 hrs., and washed with two 50ml portions of water. The 
ethereal solution was then evaporated under reduced pressure 
and the residue recrystallised from benzene (0.92g., 58%, 
m.p. 137-8°, Rf2:1 0.6). Micro canalytical data:
C% H%
Pound 53.36 4.24
Calculated 53.02 4.41
1
Table 2.13 H n.m.r. spectral data of 2-chloroorcinol 
(D?0; using DSS as reference).
Signal position No. of protons Assignment
CiPPm)
6.4 2(br. s ) Ar-H
2.4 3(s) Ar-CH^
The mass spectral data:
M+ peaks at m/^ e 160 and 158 (3:1)
Base peaks at m / e 160 and 158 (3:1)
(B) To a 10ml aqueous solution of 5-chloroorsellinic acid 
(I8.0mg ) a solution of 2M HCl (2 drops) was added, and the 
reaction mixture refluxed for 2 days. The solution was eva­
porated to dryness (12.0mg ) and thin-layer chromatography 
using CHCl^ ;CH^C00H showed a spot v/ith the same Rf as the 
above mentioned mono-chlorinated compound. This compound 
recrystallised from benzene (10.2mg , m.p. 137-138°; lit."^^ 
m.p. 137°).
The melting point (137-138°c) of the products of procedure 
A and B was undepressed in the mixture, therefore the mono- 
chloro compound (A) was identified as 2-chloroorcinol. 
Preparation of 4-chloroorcinol
An .acidic aqueous solution (10ml , pH 3) of 3-chloro- 
orsellinic acid (I8.0mg ) was refluxed for 2 days. The solvent 
was then evaporated under vacuum (10.8mg ), and the residue 
recrystallised from benzene (9.1mg., m.p. 132-133°C).
2.3.17 Monochlorination of fl-resorcylic acid
Dry /3 -resorcylic acid (8.0g ) in dry ether (200ml .) was 
treated at room temperature with sulphuryl chloride (8.9g ♦ 
6.0ml ) in dry ether (50ml ). After 4 hrs. stirring, the 
reaction mixture was washed with two 50ml ; portions of water, 
and the ethereal solution was then evaporated under vacuum. 
The residue obtained was recrystallised from water (8.07g,» 
m.p. 21 6-217°C, Rf sO.71) .
Microanalytical data:
C°/o H°/o
Pound 40.62 3.20
Required (C^CIO^) 44.58 2.67
Required (C^H^ClO^HgO) 40.70 3.41
An aqueous solution of 5-chloro-/3 -resorcylic acid 
(0.2g in 20ml ,.pH-2) was refluxed for 2 days, and then 
evaporated to dryness. The solid obtained was recrystallised 
from benzene (0.95g , m.p. 106-107°C, m.p. of 4-chlororesor- 
cinol 106.5-107.5°C).
2.3.18 Preparation of orsellinie acid-4-methyl ether
(i) Diazomethane was prepared from diazald according to
"1 4- 2the method given by Vogel. In a 250ml conical flask,
diazald (6.42g) was dissolved in ether (90ml.). After cooling
- 83 -
the solution, potassium hydroxide (l.2g) in ethanol (30ml) 
was added, and left at room temperature for 5 mins. The 
reaction mixture was then distilled off, and ethereal solution
in a mixture of dry ice and acetone.
In a 250ml conical flask, equipped with a magnetic stirrer, 
orsellinie acid (l.68g) in methanol (40ml) was gradually 
treated with pre-produced diazomethane in ether, at room 
temperature. After 1 hr. stirring, the reaction prodcuts were 
dissolved in 2M NaOH (20ml). The solution was then refluxed 
(2 hr), cooled, acidified with 3M HC1 (pH 2), and extracted 
with two 50ml portions of ether. The combined ethereal extract 
was in turn extracted with two 50ml portions of 0.1M NaHCO^ 
and the combined sodium bicarbonate extracts then acidified 
to pH 2. After the extraction of this solution with two 50ml 
of ether, the combined ethereal extract was evaporated under 
vacuum, and the residue obtained then recrystallised from 
ethanol-water. The crystals were collected and dried in a 
vacuum oven (30°C) within 10hrs.,(1.41g , m.p. 174,(157)°c)*
1
Table 2.14 H n.m.r. spectral data of orsellinie acid-4-
collected in a flask which had been cooled previously to -70°C
methyl ether (d^-acetone).
Chemical shift 
( j> p.p.m.) No. of protons Assignment
6.34
6.32
3.82
2.54
K b) 
1 (s) 
3(s) 
3(s)
Ar-H(between OH and OMe)
Ar-H(between OMe and Me)
Ar-OCH,—3
Ar-CH*
-3
1 i q
2.3.19 Preparation of O-methyl orcinol
A mixture of dry orcinol (1.24g) and potassium carbonate 
(2.1g) in dry acetone (40ml) was refluxed with methyl iodide 
(0.95ml) for 8 hrs. The reaction mixture was then acidified 
with 0.5M HgSO^ (pH 2) and extracted with three 50 ml portions 
of ether. The combined ethereal extract was evaporated under 
vacuum, and orcinol monomethyl ether was then separated by 
column chromatography using CHCl^JCH^COOH (95:5 v/v) as eluent 
(0.516g, m.p. 133-4°C, Rf ^0.72). . .
1
Table 2.15- H n.m.r. spectral data of 0-methyl orcinol 
(d^-acetone).
Chemical shift
( S p.p m ) No. of protons Assignment
6.4 3(br.s) Ar-H
3.9 3(s) Ar-O-CH^
2.45 3(s) Ar-CH^
2.3.20 Sulphonation of orcinol
The following methods were utilised, which parallel those 
given for the synthesis of 1,3-dihydroxyjbenzene -4-sulphonic 
acid.
(i) Using H^SO^1^
The mixture of orcinol (0.71g) and conc. ^ S O  (0.5ml) 
was heated for 3 hrs. It was then dissolved 
in water (100ml) and extracted with two 50ml portions of 
ether. The combined ethereal extracts were concentrated (20ml).
This solution on thin-layer chromatography using CHCl^ and 
CH^COOH (9:1v/v) showed 4 spots and the main component was 
found to be unchanged starting material.
(ii) Using CISO^H.1^
Orcinol (1.42g ) was dissolved in nitrobenzene (5ml ) 
and slowly treated with the solution of CISO^H (0.67ml ) in 
nitrobenzene (1.7ml ) with stirring for 3 h r a t  40°C. The 
solid was filtered under vacuum, washed with five 20ml 
portions of benzene, and it was then dried in a vacuum oven 
(0.356g ). This solid was observed to, liquefy '' when 
exposed to air, and to undergo a rapid degradation on filter 
paper to a black residue. Prom its n.m r spectrum 
(in I^O, using D S S as internal standard), it was identi­
fied as orcinol disulphonic acid.
Chemical shift No. of protons Assignment
( € p.p.m.)
2.3 3(s) Ar-CH^
.6.35 1 (s) Ar-H
\45
(iii) Using I^NSO^H.
The mixture of orcinol (l.42g ) and NI^SO^H (0.44g ) 
was heated (50°C) and stirred for 2 hr;/. The reaction mixture 
was then dissolved in water (20ml ) and extracted with ether. 
Ethanol (20ml ) was added to residue, the mixture filtered 
and the filtrate was concentrated. This was kept
at 4°C for 20 days, the crystals obtained were collected and 
recrystallised from ethanol (0.160g , m.p. 226-228°C). Its 
n.m.r. spectrum in D2O, using D S S as internal standard, 
showed two peaks at 2.12p.p.m. (3s), and 6.2p.p.m. (1s)*
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Biosynthesis of Penicillic Acid.
3.1.1 Introduction
The growth and replication of P .cyclopium, like any other 
fungus depends upon environmental conditions such as; tempe­
rature, aeration and nutritional factors. 'Detailed knowledge 
of various aspects of the course of metabolism is essential 
before attempting the exploration of individual metabolic 
pathways. An attempt was therefore made to examine the course 
of fermentation of P .cyclopium, on Raulin-Thom medium, and 
its relationship to the biosynthesis of penicillic acid.
The detection, isolation and identification of peni­
cillic acid (4) and biosynthetically related metabolites 
was carried out using thin-layer chromatography and u.v. 
spectroscopic analysis of the chloroform extracts of acidi­
fied metabolism solutions. In addition to penicillic acid 
(4) and orsellinie acid (1) two other metabolites, 3-methoxy- 
2,5~toluquinone (3) and 3-methoxy-2,5-toluquinol (2) were 
also isolated from culture filtrates of submerged cultures 
after 3 days’ growth.
The rate of growth of this fungus is at its maximum 
between 2 and 5 days in the submerged culture, and from 5 to 
10 days in surface culture. The highest rate of penicillic 
acid biosynthesis in submerged cultures occurs between 3 and 
4 days after inoculation. This was confirmed by the result
 ^1
of the incorporation of C-labelled acetate into penicillic 
acid. Under the same conditions, the incorporation of
- 90 -
U
14
C-labelled formate was found to be similar as that of
C-labelled acetate.
P .cyclopium did not grow well on the Czapek-Dox medium 
and no penicillic acid was detected in the metabolism 
solution.
CH
COOH
HO OH
(1)
0CH_ 0
(2)
OCH
(3)
H^ CO*
h 2c
3 H3C
-0 
OH
(4)
3.1.2 Results and discussion
A high yielding culture of P .cyclopium^*1^  (IMI,89372) 
was used in the present investigations. It grows well on 
potato dextrose agar (P.P.A.) slopes and Raulin-Thom medium 
which was consequently used for the present biosynthetic and 
inhibition studies. Czapek-Dox medium was however used for 
some trial experiments with this fungus.
3.1.2.1 Growth of P.cyclopium.
(A) Slopes grown on P.D.A. at 24°C, formed white mycelium 
after only 24 hours :, changing to dark green'following sporu- 
lation after a further 2 days.
(B) Surface cultures grown on Raulin-Thom medium at 24°C, 
covered the surface with a thin white mycelial pad after
2 days. tIt grew with deep folding from the edges and thickened 
from the third day until the fifth or sixth day. At this stage 
the mycelium became grey on the surface and creamy yellow on 
the underside, while the colour of the metabolism solution 
changed from pale yellow to brown. After this period, an 
increase in the amount of mycelium and a change in the colour 
of the metabolism solution to deep brown were the only subse­
quent differences to be observed.
(C) Submerged cultures grown on Raulin-Thom medium at 24°C, 
formed small white spheres of mycelium after 24 hours. These 
grew rapidly between one and three days. At this stage the 
mycelium started to develop a brown colouration becoming 
completely brown after 4 days’ growth; the metabolism solution 
was coloured pale brown.
A large variation in mycelial growth was observed in 
submerged cultures, which were inoculated directly from 
suspended spores. More uniform growth was obtained on using 
an inoculum of vegetative mycelium after initial incubation of 
the spore-inoculated medium for 30 hours. This procedure gave
a good growth response with minimum variations in mycelial 
yield.
P.cyclopium did not grow well on Czapek-Dox medium 
either in surface or submerged cultures.
3.1.2.2 Course of fermentation.
A number of submerged cultures were harvested at varying 
times ranging from 1 to 8 days after inoculation. The same 
experiment was carried out for surface cultures ( 5 to 15 days 
of growth). Data observed included mycelial weight , residual 
glucose, pH of culture filtrate and the yield of its chloro­
form extract; these were plotted against the age of the 
culture (Pigs. 3.1 and 3.2).
As shown, rapid changes during growth in submerged cul­
tures appear between 2 and 4 days, the corresponding change 
in surface culture occurs between 5 and 9 days. In both 
instances, the pH variations showed that the minimum pH occurs 
at the stage of maximum yield. The decrease of pH during the 
course of metabolism could be related to the consumption of 
nitrogen which is present in the medium as ammonium salts, 
the NH^ ions being replaced by H. Rapid growth of the fungus 
in submerged cultures rather than in surface cultures is 
due to more efficient aeration under these conditions.
The rate of glucose consumption is consistent with the high 
metabolic activity of this fungus during the growth 
phase. The subsequent decrease in mycelial weight
Fig. 
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is not accompanied by a significant increase in penicillic 
acid concentration and probably represents the stage when 
autolysis starts.
3.1.2.3 Isolation of P.cyclopium metabolites.
Penicillic acid and its related intermediates were 
found to exist in the metabolism solution. Since the complete 
solvent extraction of intermediates which have phenolic 
characteristics was not possible above pH 3, the filtrate was 
adjusted to pH 2 before extraction. Chloroform was a satis­
factory solvent for extraction of the metabolites from 
culture filtrates. The detection, isolation and identifica­
tion of penicllic acid and its bio synthetically related 
metabolites was carried out using thin-layer chromatography 
and spectrophotometric analyses of the chloroform extracts 
of the metabolism solutions.
Results of thin-layer chromatography showing the course 
of the fermentation in submerged cultures are listed in 
Table 3.1. Among the components existing in the chloroform 
extracts the metabolites. C,D,E and H were found to be 
associated with the pathway of penicillic acid formation, 
however the relationship of the other components to this 
pathway is still unknown. Components P and G appeared as 
bright blue fluorescing zones on irradiating at 350nm.
-  y o  -
^ \ n ^ trt 'v 11 C XI V 01
growth
A B C D E F Gr H I
2 + + + ++
3 + + + ++ + + + + +
4 + + + ++++ + + + + +
5 + + ++++ + + +
6 + + ++++ + +
7 + + ++++ + +
Table 3.1 Results of thin-layer chromatography of chloroform 
extracted materials obtained from media of P. cyclopium in
submerged cultures t.l.c., silica G-F 254, 0.25mm, with
CHC13:CH50H:H20:HC00H = 250:25:24:1 (organic phase)J . •
Component Rf Chromatographically equivalent
substances
A ^ 0.1
B z-' 0.15 Orcinol
G ^ 0 . 2  Orsellinic acid
D ^ 0.35 Penicillic acid
E ^0.45 3-Methoxy-2,5-toluquinol
F ^ 0.6
G 0 • 8
H '•" 0.85 3~Methoxy-2,5-toluquinone
I ^ 1
Their mass spectra showed the following molecular ions:
M(F) 254 and 444. Since A,F,G and I were observed
at all stages of growth (Table 3.1) they are possibly unrelated 
to the biosynthetic pathway leading to penicillic acid.
As shown in Table 3.1, on the basis of thin-layer 
chromatography, orsellinic acid was detected in chloroform 
extracts of 2 day old submerged cultures. This was confirmed 
from the u.v. spectra of the above residue in ethanol (A = 254) 
and the original filtrate ( X=257) (ca.= 0.5mg/flask). The 
normal levels of orsellinic acid in the surface culture 
were examined by Bentley and Keil^ , who found that the 
filtrates of surface cultures on the 3rd and 7th days of 
growth respectively contained 0.002mg and 0.015mg per ml 
of orsellinic acid. The chemical structure and spectral 
characteristics of this compound have been extensively 
discussed in chapter 2.
Orcinol in trace amounts was found on thin-layer 
chromatograms of the chloroform extracted filtrate after 
the third day of growth. It is possible that this compound 
resulted from a non-enzymatic decarboxylation of orsellinic 
acid.
119Axberg and Gatenbeck  ^ found, through radioisotopic
tracer experiments,that 3-methoxy-2,5-toluquinol (2) and
its related quinone (3) were incorporated into penicillic
1 A-nacid. Subsequently Better and G-atenbeck isolated
compound (2) from the metabolism solution of P.baarnense 
growing on Czapek-Dox medium. In addition to barnol
14-8this fungus produces orsellinic acid and penicillic acid.^
CH
HO
HO CH
3
OH
Barnol
It was found that the relative yields of these substances 
are dependent on the growth medium, i.e., when Czapek-Dox 
medium was used orsellinic acid and penicillic acid formed 
in substantial amounts, whereas only a trace amount of 
barnol was detected, but on Raulin-Thom medium the fungus 
produces barnol as the main metabolite.
An attempt was made to establish whether’ or not' .
3-methoxy-2,5-toluquinol can be bio synthesised from 
P. cylcopjum. Chloroform extracted residues of submerged R-T 
cultures on thin-layer chromatography indicated (after 3 days 
of growth) the presence of compounds (2) and (3) v/hich was 
confirmed by comparison with authentic samples. Under the 
above conditions, typical yields were 1.6mg and 2.1mg per 
50 nil of submerged culture. These compounds were crystallised
-from carbon tetrachloride, when 3-niethoxy-2,5-toluquinol
was obtained as white needles, m.p. 131-132°C, \ ^290nm7 7 A max
(£ =3830). 3-Methoxy-2,5-toluquinone was obtained as 
yellow crystals ( exCCl^), m.p. 155-156°C, X max ^4nm
(£ =4178).
Using a two dimensional silica gel (GF254) thin-layer 
chromatogram, it was found that 3-methoxy-2,5-toluquinol 
is readily oxidised in air to the related quinone. Both 
compounds were observed as dark spots when viewed at 350nm. 
The mass spectrum of compound (3) showed a molecular ion 
peak at M 152 (100%) and further abundant fragments were 
seen at m/e 137 (32%), m/e 122 (100%) and m/e 109 (60%).
The n.m.r. spectral data for this compound are listed in 
Table 3.2 -
Table 3.2 N.m.r. spectral data (in CDCl^) of 3-methoxy- 
2,5-toluquinone (3).
Chemical shift (^ p.p. m.) No. of protons Assignment
2.04 3 i o
3.79 3 -0CH,-5
5.98 1 V
6.6 1 Ha
CH
‘E
0 OCH
Ha
(3)
Penicillic acid differs from other tetronic acids in
being optically inactive and does not give the usual colour
79test with aqueous ferric chloride. Bentley and Keil 
described a colorimetric method for the estimation of peni­
cillic acid which is based on the development of a red colour 
with concentrated ammonia. They initially utilised optical
density measurements at 545nm after 10 minutes at room tempe-
149rature. Later it was found that the optical density did
not stabilise even after 1 hour. It was, however, useful as 
a sensitive qualitative test.
Since the u.v. spectrum of penicillic acid in ethanol
on
gives a characteristic peak at 225nm (6=12830, lit. 6=12750), 
it was utilised as the basis of an assay procedure in the 
present study. It was found that penicillic acid appeared 
as the principal culture filtrate metabolite after the third 
day of growth in submerged cultures (Table 3.1). As shown 
in Pig. 3.3, the fungus has the highest capability of 
penicillic acid biosynthesis between 3 and 4 days1 growth.
"1 4*This was confirmed by the rate of incorporation of (1- C)- 
labelled acetate into penicillic acid using mycelia of 
varying age.
As shown in Fig. 3.2, the biosynthesis of ^ penicillic 
acid in surface cultures starts around the fifth day with 
the maximum production occurring about 11 days after 
inoculation. <
As previously mentioned (p. 14) the carbon skeleton 
of penicillic acid is derived from 4 acetate units, the
O-methyl carbon corresponding to a unit (ex-methionine
7 ^  "14- 1A
or formate). (1- C)-acetate and C-formate were incor­
porated with similar efficiencies (3.97% and 3.85% respec­
tively) .
-j j
The efficiency of incorporation of C-labelled acetate 
was observed to parallel approximately the rate of formation 
of penicillic acid (Fig. 3.3).
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The biosynthesis of penicillic acid via a 1 ,2-cleava'ge oJ
112orsellinic acid was suggested by Birch , following an
/ 14 \
investigation of the incorporation of (1- Cj -acetate 
(Scheme 3.1, path fa’). However, chemical degradation of 
penicillic acid derived from ’1 4,
1
14 1C-carboxy and 2- C - 
orsellinic acid, led Mosbach ' to conclude that cleavage 
of the ring occurs between C(4) and C(5) (Scheme 3.1, path 
'b 1) •
path 'a1 
1,2 cleavage
CO^H
(0
path *b*
4,5 cleavage
MeO
COoH
Me
< ^ 6  
*2° f  .1
OMe
MeO
C
Me
4
5
6h x0
0
MeO
H2 ^ 6  
■> c
| OH 0 0
Me
Scheme 3.1 Alternative hypothetical cleavages of the aromatic 
ring of orsellinic acid(j).
Further support for the Mosbach mechanism was provided 
by Al-Rawi et al.  ^ from the interpretation of [^h] - n.m.r. 
spectra of penicillic acid obtained from tritiated acetate, 
which led to the suggested epoxide scheme (3.4, path b) 
for the biosynthesis of penicillic acid from orsellinic acid. 
The operation of the C(4) and C(5) cleavage of the ring 
followed from the presence of tritium on C(5) . The observed 
selective partial exchange of tritium at C(5) of the hypo­
thetical chiral intermediate (8), could result from the rapid 
enzyme-catalysed sterospecific isomerisation of (7) to (8), 
coupled together with a slow simultaneous non-enzymic rever­
sible interconversion of these intermediates. This would 
effect some loss of tritium and in the reverse direction would 
yield a racemate of C(8). Seto et alj ^  have also obtained
evidence for a C(4)-C(5) cleavage of the aromatic ring based 
13on C n.m.r spectral data of penicillic acid derived from 
13(1,2- C)-acetate. They observed spin-spin coupling between 
C(2) and C(3) as well as G(6) and C(7), which contrasts with 
the coupling required for a pathway involving C(1)—C(2) clea­
vage.
o 
vn
4,5 cleavage
CH
HOOC OCH
OH
1,2 cleavage
CH
CH
COOH
1
C2
OH 0CH
1 "5 1 ^Scheme 3.2 Possible mode of incorporation of C- C doubly 
labelled acetate into penicillic acid(4,) .
MeO
0
Axberg and Gatenbeck11^ on the basis of labelling 
studies suggested Scheme (3.3) for the biosynthesis of 
penicillic acid. This invloves a Baeyer-Villiger type 
of oxidative ring opening reaction. The final step in this 
scheme requires a reduction of the product of B'aeyer-
Villi.ger reaction (5) 151
Y  Baeyer-Villiger MeO
oxidation
Me
(5)
Reduction
MeO
HO
Me
Scheme 3.3 Baeyer-Villiger type of oxidative ring opening'
1 1 Q
reaction (Axberg and Gatenbeck. )
As shown,the partial loss of tritium on C(5) cannot be 
directly explained by a Baeyer-Villiger type of reaction.
This together with the higher oxidation state of (5), neces­
sitating a final reductive step, allows at least two possible
pathways based on the following epoxide Schemes (3.4; A and 
152B) for the biosynthesis of penicillic acid. As indicated
(page 99), the ease of oxidation of the quinol (2) to the
related quinone (3), suggests that compound (3) may not be
a true intermediate in the biosynthetic pathway of penicillic
acid, since it is readily formed on aerial oxidation of
3-methoxy-2,5-toluquinol in media and on tlc-chromatography.
117It has recently been demonstrated that phyllostine (10)
is an intermediate in the formation of patulin (11). Its
structural similarity to epoxydon (9), which has been isolated
153from Phyllosticta species , would be consistent with the
mediation of epoxydon in this biosynthetic pathway* as shown
in Scheme (3.5). The aromatic ring cleavage involved in
penicillic acid (4) formation and also that leading to
patulin (11) are both unusual, in that they require a lower
degree of oxidation than the majority of known oxidative
113ring scissions. This could support a mechanism such as 
that obtained in Scheme (3.4, A), involving cleavage through 
the hypothetical epoxide (6), which exhibits a close 
structural similarity to patulin-precursor epoxydon (9).
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3.2 Inhibition studies
3.2.1 Introduction
Current knowledge of advanced stages involved in the
biosynthesis of a wide range of secondary metabolites,
suggests the feasibility of a rational approach to the
strategic design of selective antimetabolites. In principal,
this parallels the classical application of competitive
inhibitors to the interception of primary metabolic pathways,
such as the specific inhibition by fluorocitrate (12) of
154 155the citric acid cycle enzyme aconitase, 1 ' the inhibition
156by sulfanilamide (l4)of the biosynthesis of folic acid 
(16), and that of succinic dehydrogenase by malonate (17). 
This competitive inhibitory effect arises from the structural 
similarity of the inhibitor to a normal metabolite in the 
specific pathway under consideration (Pig. 3.5).
In a sequence involving cleavage of a carbon-carbon 
bond, cultivation of the parent organism, in the presence 
of suitably modified intermediates carrying additional 
substituents at either of the two key carbon atoms, could 
conceivably selectively inhibit the relevant enzyme responsible 
for this cleavage reaction. This is a predictable consequence 
of the competition between a normal intermediate and its 
analogue for an active site on the enzyme catalysing that 
specific step. When applied to secondary metabolic pathways, 
such antimetabolites need not necessarily inhibit any of 
the essential primary metabolic processes involved in growth 
and cell reproduction.
-  I I J
Inhibitor Normal Metabolites
CH. co2h
c h (o h)-co2h
CHF - C02H
(12)
CH2 — co2h
c h (o h )-co2h
I
CH2~C02H
(13)
S02NH2 00 „H
(14) (15)
OH
H2
CH
H0„OCHo-CH- CH2 W 2 2 I
(16)
HOOC
COOH
I
ch9
I
COOH
COOH
(ch2)2
COOH
(17) (18)
OHR.
Inhibitor b r2 b b b
Orsellinic 002H H . H . H. Me
5-Chloroorsellinic acid co2h H H Cl Me
3-Chloroorsellinic acid co2h Cl H H Me
2,5-Dichloroorsellinic acid co2h Cl H Cl Me
3,5-Dibromoorsellinic acid co2h Br H Br Me
Orsellinic acid-4-methyl 
ether
go2h H Me H Me
ft -Resorcyclic acid go2h H H H H
5-Chloro-ft -resorcyclic acid go2h H H Cl H
Orcinol H H H H Me
2-Choroorcinol H H H Cl Me
Orcinol-monomethyl ether H H Me H Me
Resorcinol H H H H H
3.6 Some inhibitor candidate phenols.
In the present study, it has been demonstrated that the
biosynthesis of penicillic acid is selectively inhibited by
low concentrations of 5-chloroorsellinic acid (20), (Fig. 3.6),
Cultivation of P. cyclopium with 5-chloroorsellinic acid
was found to stimulate the accumulation of 3-methoxy-2,5-tolu-
quinone and the corresponding quinol, both of which have been
reported as intermediates formed prior to cleavage of the aro- 
'119matic ring J
The inhibitory effect of the candidate inhibitors was 
also examined using an autoradiographic procedure previously
applied to a study of the biosynthesis of penicillins from
14 35 158
C- and S-labelled precursors . The selective nature
of the inhibitory effect was clearly apparent on inspection
of autoradiograms, which not only confirmed the inhibition
of penicillic acid formation by 5-chloroorsellinic acid, but
also detected the accumulation of other probable intermediates,
including orsellinic acid, 3-methoxy-2,5-toluquinol and its
related quinone.
3.2.2 Results and Discussion.
Cultivation of P. cyclopium was carried out in the pre­
sence of a variety of concentrations of 5-chloroorsellinic acid 
(20). ^The yield of penicillic acid, mycelial growth and also 
subsequent growth (i.e.; growth during to the period of cul­
tivation in the presence of the inhibitor relative to the 
control), are illustrated graphically in Fig. 3.7'.(a) . In this
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case, the inhibitor was added after 30 hours growth, and the
cultures were harvested after a total of 6 days incubation.
These results demonstrate the selective inhibition of
penicillic acid biosynthesis under conditions which only
partially restrict growth relative to that of the control.
Thin-layer chromatograms obtained from chloroform extracts
of acidified culture filtrates showed the inhibition of
penicillic acid formation by 5-chloroorsellinic acid and also
detected the concomitant accumulation of other metabolites;
such as 3-methoxy-2,5-toluquinol and 3-methoxy-2,5-toluquinone.
The maximum accumulation of these intermediates was observed
/- -4at a concentration of 8.6x10 M of 5-chloroorsellinic acid.
Under these conditions no penicillic acid was obtained and
the yield of the quinone was approximately 0 .07mg/ml of
culture filtrate.
An autoradiographic approach was used to examine the
metabolic activity in the presence of inhibitors. This
technique was based on that previously applied to a study
14 35of the biosynthesis of penicillins from C- and S-labelled 
precursors.1 ^^C-labelled acetate was utilised to demon­
strate the formation of penicillic acid, since its carbon 
skeleton is known to be derived from four molecules of this 
precursor.
fresh mycelium was grown (72 hours) in submerged culture 
and resuspended in water in the presence of 5-chloroorsellinic 
acid (4.9x10 ^M), and (1 -^C)-acetate (^w.Ci/2ml). Autoradio-
'. Front
3-Methoxy-2 y 5-toluquinone
*r Penicillic acid
Orsellinic acid 
Rj- =Orcinol
Origin
Fii 3. Autoradiogram showing the effect of orsellinic acid 
(OA) analogues on penicillic acid formation.
No . OA derivatives
a Concn. 
Mx 10 4
1 OA 14.8
2 5-Chloro-OA 4.9
3 Control 0
4 0A-4-methyl ether 1.37
Activity of CHC1,, ext. 
c.p.m.x10-4
5.3
1 2 . 8
45.7
23.2
h
a) Addition to resuspended P .cyclopium mycelium (72hr old 
submerged culture) plus (1 -1 ^ C)~acetate ( 6. 66x106cpm/2ml) .
b) CHC1.. extract of acidified filtrate (2ml) after I6hr. 
incubation.
I ' J
> Front
3-Methoxy~2,5-tolu­
quinone
♦ Unknown (C)
Unknown (B)
* 3-Methoxy-2 , 5-toluquinol 
* Penicillic acid
— Orsellinic acid
— * R|- = Orcinol
> Unknown (A)
— >  Origin
Fig. 5.9 Autoradiogram showing the effect of different 
concentrations of 5-chloroorsellinic acid on 
penicillic acid formation.
No. Concentration Activity of CHCl^ ext.
(Mx10 ^) (c.p.m.xIO^)
1 3.08 9.3
2 1.2 13.9
3 0.3 8.3
4 0.185 23.4
5 0.12 22.3
6 0 33.2
graphic comparison (Fig. 3.8) of chloroform extracts obtained 
from this culture and that of a control, clearly confirmed 
that 5-chloroorsellinic acid not only inhibits penicillic 
acid formation but also stimulates the accumulation of other 
known intermediates, namely orsellinic acid (1) and 3-methoxy- 
2,5-toluquinol (2) and the related quinone form. Continua­
tion of the above experiment with lower levels of 5-chloro­
orsellinic acid concentration showed that the inhibitory
-5effect is still apparent at 1.2x10 M (Fig. 3.9). As shown, 
the rate of accumulation of the precursors of penicillic 
acid [e.g. compounds (1) ,(2) and (3) ] depends on the 
concentration of the inhibitor., The maximum yield of these 
metabolites occurs at the level of 3.08x10”^M concentration 
when penicillic acid is no longer produced. This indicates 
the selective nature of the inhibitory effect of 5-chloro­
orsellinic acid on penicillic acid biosynthesis. The role 
of other components existing in chloroform extracts (e.g. 
compounds A, B and C) is still unknown. Since these compounds 
are present in all chloroform extracts they may well be 
unrelated to the biosynthesis of penicillic acid.
To determine whether 5-chloroorsellinic acid is converted . 
to the chloro derivative of the intermediates of penicillic 
acid, the fungus was cultivated in the presence of (3- H)- 
5-chloroorsellinic acid. Thin-layer scanning of the chloro­
form extract of the culture medium only detected the presence 
of the corresponding chloroorcinol formed by loss of CO^i in 
addition to unchanged starting material (40.7%). This decar­
boxylation occurs spontaneously on incubating the chloro- 
orsellinate with sterile medium adjusted to pH 3 for 5 days 
at 24°C, consequently it is unlikely that this reaction is 
catalysed by any of the enzymes involved in the normal bio­
synthetic pathway leading to penicillic acid. Similar results
were obtained on incubating freshly grown mycelium with a
•2
low concentration of [3- H ]-5-chloroorsellinic acid for 
18 hours.
In a further experiment, the fungus was grown in the 
presence of 5-chloroorsellinic acid for periods of 60 hours 
to 4 days, when penicillic acid biosynthesis was completely 
inhibited. The resulting mycelium was subsequently used to 
prepare an autoradiogram which demonstrated its ability to 
form penicillic acid and also 3-methoxy-2,5-toluquinone 
(Fig. 3 ®10). This finding indicates the selective role of 
the inhibitor in blocking the active site of a corresponding 
orsellinic acid metabolising enzyme. This contrasts with 
the accumulation of intermediates by auxotrophic mutants, 
which is a consequence of the absence of genes responsible 
for the biosynthesis of individual enzymes in essential 
metabolic sequences. It was also observed that mycelium, 
grown in the presence of inhibitor concentrations which 
completely block penicillic acid formation, is able to 
resume production of this acid on resuspending in water in 
the absence of inhibitor.
Front
— - J
3-Methoxy -2,5-toluquinone*--- - i
Unknown "
a
Penicillic acid ** ’
.
Origin *
Fig. 3.10 Autoradiogram showing the incorporation of 
”1 4 -(1- C)-acetate into penicillic acid with a culture 
previously grown in the presence of 5-chloroorselli­
nic acid.
The mycelium was cultivated in the presence of the 
inhibitor (8.6x10 ^M) over the growth period 
60-96 hr. prior to resuspending in aqueous ^C-ace- 
tate^ but without further addition of 5-chloro- 
orsellinate.
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On the basis of the results of autoradiographic studies 
to determine the optimum concentration of inhibitor, an experi­
ment was carried out to measure the percentage of acetate 
incorporation into 3-methoxy-2,5-toluquinone. In this 
experiment, the mycelium of a 50ml submerged culture (72 
hours) was resuspended in a modified Raulin-Thom medium, and 
incubated with [2-^C ] -acetate (200^Ci) in the presence of 
5-chloro-OA ; the resulting quinol was then oxidised to the 
corresponding quinone. The percentage of incorporation of 
acetate and the specific activity of the quinone were found 
to be 7.14% and 6.48^dCi/mg respectively.
Since a secondary metabolite is not normally considered
to play a direct role in the growth of the parent organism,
this parameter is not likely to be directly influenced by
the presence of a, specific inhibitor of such a secondary
metabolite. However, in these studies, some inhibition of
growth in addition to secondary metabolite formation was
frequently observed at higher concentrations, which is
probably a reflection of a type of general or non-specific
inhibition common to many phenols. As shown in Fig. (3.7a)
5-chloroorsellinic acid at the level of 2.05x10 which
reduces penicillic acid formation to 64%*shows only a
negligible effect on fungal growth. The inhibitory effect
of 5-chloroorsellinic acid was examined at an early stage of
growth by incorporating the acid in the culture media prior
to inoculation with P .cyclopium. Both mycelial weight and
penicillic acid production were partially reduced (Pig. 3.11a)
relative to the experiments with established cultures 
(Pig. 3.7a).
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Pig. 3.11(a) Influence of 5-chloroorsellinic acid 
on mycelial growth and penicillic acid 
production.
(Inhibitor was added at the time of 
inoculation and mycelia harvested after 
7 days' growth).
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Pig. 3.11(b) Influence of orsellinic acid on mycelial 
growth and penicillic acid production 
cf. (a).
- I £ 0
Td
i— 1
Cl)
>5 -P
&
bfl
•H •H
O Q)
03 £
o rH
•H Oj
rH •rH
rH 1— 1
•H CD
O O
•H
G 32
0)
Ph
(orsellinic acid )
(5-chloroorsellinic acid )
Concn. (Mx10
Fig. 5.12 Comparison of the production of penicillic acid 
in the presence of 5-chloroorsellinic acid and orsellinic acid, 
(cf. Fig. 5.11).
This indicated a more pronounced general inhibition type of 
behaviour, although the relatively greater effect on peni­
cillic acid yields demonstrated some selective inhibition 
of the biosynthetic pathway (Fig. 3.12).
A corresponding series of experiments designed to exa­
mine the effect of orsellinic acid addition,both at the 
time of inoculation and to established cultures (Fig..3.7b 
3.11b), showed that this phenolic acid also behaves as a 
general inhibitor at relatively high concentrations. At 
first sight this may appear surprising since orsellinic acid 
is an apparent obligatory precursor of penicillic acid, how­
ever in view of the previous observations, this is probably 
simply another instance of the general inhibitory effect 
of phenolic substances. It is conceivable that feed-back 
control mechanisms may also contribute to the inactivation 
of earlier enzymes involved in this biosynthetic-sequence. 
Another potentially relevant inhibitory effect has been 
demonstrated for a variety of enzymes which have been 
shown to be inhibited by their own substrate at higher con­
centrations, for example the influence of pyruvate on lactic 
1 SQdehydrogenase .
Cultivation of the fungus with orsellinic acid-4-methyl 
ether showed this simple derivative to be a relatively potent 
inhibitor. The result of feeding experiments over a range 
of concentrations between 0.91 x 10~^M to 4.5 x 10”^M are 
presented in Fig. 3.7d . At a concentration of only
1.8 x 10~^M the methyl ether can reduce penicillic acid 
formation by 50%, however in contrast to 5-chloroorsellinic 
acid this inhibitor exerted an equally pronounced inhibition 
of mycelial growth. This result is consequently more cha­
racteristic of general rather than selective inhibition, 
the reduced production of penicillic acid reflecting the 
lower rate of growth and enzyme synthesis. A corresponding 
autoradiogram showed that the inhibition of penicillic acid 
formation occurred without any apparent accumulation of the 
previously - observed advanced intermediates (Fig. 3.8)*
An interesting aspect of this finding, is that orsellinic
acid 4-methyl ether occurs naturally in an esterified form
1 finin lichens as the depside evernic acid.
Me
COOHCOO
OH
Me
MeO
OH
Evernic acid
3-Chloroorsellinic acid was also fed to the growing 
culture at various concentrations. The results of this 
experiment (Fig. 3.7c) shows that this compound only appears 
to exert a general inhibitory effect on fungal growth at 
higher concentrations. At the level which with 5-chloro­
orsellinic acid reduces penicillic acid formation by 50%, 
3-chloroorsellinic acid exerts a comparatively negligible 
effect, reducing the yield by only 5%. An autoradiogram 
showing the effect of this inhibitor on the formation of 
penicillic acid is shown in Fig. 3.16 (appendix).
The results shown in Tables 3.4, 3.5 and 3.10 (appendix) 
indicated that 5-chloroorsellinic acid and the 3-chloro 
isomer exhibit slightly higher inhibitory effects than some 
other phenolic compounds, including f-resorcylic acid, 
resorcinol, and orcinol, possibly reflecting a specific effect 
of the chlorine atom. Autoradiograms obtained on incubation 
of the mycelium with p -resorcylic acid, 5-chloro-f-resor- 
cylic acid and 3-chloroorsellinic acid are shown in Fig. 3.16 
(p.137). The results showed that 5-chloro-^-resorcylic acid 
effected a greater inhibition of penicillic acid formation 
than ^-resorcylic acid, but ,the effect was less pronounced 
than that of 5-chloroorsellinic acid which under these 
conditions resulted in ^90% inhibition. As also shown in 
these autoradiograms, 5-chloroorsellinic acid alone stimulated 
the accumulation of 3-methoxy-2,5-toluquinone.
Further investigation of the effect of halogen substituents
on fungal growth was carried out using 3,5-dibromoorsellinic
acid. As shown in Table 3.10 (appendix) pronounced inhibition
of growth was observed; thus the fungus was not able to grow
-4when cultivated at a concentration of 2.56x10 M of the
dibromo compound. Dibromoorcinol was recovered from chloroform
extracts of the acidified media used in these experiments,
which shows the ease of decarboxylation of dibromoorsellinic
acid similar to the effect previously observed with £3- r 3“
5-chloroorsellinic acid (page 121).
A general inhibitory effect of 3,5-dichloroorsellinic
acid was also observed under standard autoradiographic
conditions (Fig. 3.18, p.139). At a concentration of 
-51.05x10 M, penicillic acid biosynthesis was reduced to 56%
14as estimated by uptake of C-acetate; with this inhibitor
no accumulation of the biosynthetic intermediates was observed.
A comparable effect was also observed with 2-chloroorcinol
at a level which with orcinol showed no significant effect, '
indicating that the chlorine substituent is responsible for
the inhibitory effect activity (Fig. 3.17; appendix).
Orcinol monomethyl ether and orcinol were also fed to
growing cultures of P .cyclopium. The results (Table 3.10,p.145)
show that where orcinol exerts slight, non-specific inhibitory
activity (i.e. growth and penicillic acid production) at 
-31.34x10 M, orcinol monomethyl ether profoundly inhibits the 
biosynthesis of penicillic acid, the effect on growth being
- 130 -
less pronounced. These results were also confirmed "by 
autoradiographic studies (Fig. 3 . 1 7 ’appendix).
Typical results of the relative inhibitory effects of 
low concentrations of selected orsellinic acid derivatives on 
the metabolism of P. cyclopium are demonstrated in Table 3.3. 
While 5-chloroorsellinic acid effectively blocks penicillic 
acid formation at levels which only partially reduce mycelial 
growth, orsellinic acid 4-methyl ether inhibits both growth 
and penicillic acid formation at appreciably lower concen­
trations. In contrast,3-chloroorsellinic acid exhibits only 
slight inhibitory activity. This is consistent with the idea 
that interference with the normal orsellinic acid substituents 
at carbon atoms 4 and 5 (i.e. OH and H respectively) may se­
lectively inhibit the C(4)-C(5) cleavage involved in the 
pathway leading from orsellinic acid to penicillic acid.
The selective nature of the inhibitory effect of low 
concentrations of 5-chloroorsellinic acid is clearly apparent 
from the results shown in the composite autoradiogram (Fig. 
3.13), which also demonstrated the concomitant accumulation 
of other metabolites (i.e., 3-methoxy-2,5-toluquinol, the 
corresponding quinone, and orsellinic acid), the yields of 
which were dependent upon the concentration of the inhibitor, 
(cf . A-j and ) .
Orsellinic Concn.10 Mycelial wt.0 Penicillic acid yield
acid deri­ Mx10~4 mg/flask % growth mg/flask °/i growth
vative a
0 542 100 34.0 100
Orsellinic 2.5 563 104 35.5 104
acid (OA) 5.0 560 103 35.0 102
9.9 561 104 28.5 84
0 475 100 36.0 100
2.1 462 97 22.0 61
5-Chloro-
4.1 396 83 11 .0 31
OA 8.2 320 67 1 .5 4
0 470 100 30.5 100
3-Chloro- 2.1 438 93 30.5 100
OA 4.1 465 99 31.5 103
8.2 370 79 12.5 41
0 369 100 25.5 100
OA-4-methyl 0.9 339 92 19.0 75
ether 1.8 287 78 12.5 49
2.7 191 52 0 0
Table 3*3 Influence of orsellinic acid analogues on mycelial 
growth and penicillic acid production of P . cyclopium.
(a) Addition to culture after 30 hr. growth at 24°C.
(b) Initial concentration of orsellinic acid and 
its analogues.
(c) Mycelial weight 6 days after inoculation (average 
of duplicate flasks).
-  \ -
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Fig. 3.13 Autoradiograms showing the influence of 5-chloro­
orsellinic acid on penicillic acid formation.
The effect of incubating P .cyclopium mycelium with 
(1-14C)-acetate in the presence of 5-chloroorsellinic 
acid at 2.47x10_4M (A^) and 4.90x10~4M (B^) is shown 
relative to controls obtained with HgO (A^ and £2)*
Conclusion
The finding that penicillic acid accumulation is in­
hibited at sub-lethal concentrations of 5-chloroorsellinic 
acid, supports the concept that this derivative of orsellinic 
acid selectively combines with an active site on the enzyme 
which catalyses cleavage of the aromatic ring. It also sup­
ports the view that penicillic acid is a secondary metabolite 
which is not directly essential to cell growth and reproduction. 
In addition, it demonstrates the feasibility of this strategy 
for designing selective inhibitors of secondary metabolism
based on a knowledge of the advanced stages in. a biosynthetic 
sequence.
In respect of the enhanced formation of advanced inter­
mediates which occurs in the presence of the 5-chloroorsellinic 
acid, this corresponding characteristic has been frequently 
observed in studies with auxotrophic mutants. . "Here the 
accumulation of an intermediate in a particular pathway i'sl> 
typically a consequence of the deletion of genes responsible 
for the synthesis of specific enzymes in the normal metabolic 
sequence. In the present context, the primary effect of the 
inhibitor would not be expected to influence the biosynthesis 
of the cleavage enzyme, but rather serve as an antimetabolite 
which competes for access with the normal substrate for its 
active, site.
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3*14 Autoradiogram of culture filtrate extracts of
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Fig. 3.13 Autoradiogram showing the uptake of acetate by 
(cf. p.115) mycelium of P.cyclopium, at different times of
incubation in the presence of 5-chloroorsellinic 
acid (2.47x10”^M).
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Fig. 3.16 Influence of some phenolic compounds on resuspended 
(cf. p.128) mycelium (72hrs.) of P.cyclopium.
No. Phenolic compound Concn. (Mx10 ^c^p^r^xhO""^)
1 3-Chloro-OA 2.47 19.6
2 3-Chloro-OA 6.17 3.2
3 Control (1) 0 30.3
4 Control (2) 0 32.3
5 5-Chloro-0A 2.47 12.0
6 Orcinol 4.0 34.6
7 6-Resorcylic acid 3.2 31 .8
8 5-Chloro- -resor-
cylic acid 2.6 24.0
Front
♦ Unknown
* Unknown
Penicillic acid
Origin
Fig. 3.17 Autoradiogram showing the effect of orcinol and 
(cf. p.129) its derivatives on penicillic acid production.
No .
Orcinol
derivatives
Concentration Activity of CHC1 
(Mx10 (c.p.m.)x10 ^
3
1 Orcinol mono­
methyl ether 0.72 3.6
2 Orcinol 1 .61 45.3
3 2-Chloro orcinol 1 .89 12.6
4 2-Chloroorcinol 1 .26 16.0
5 2-Chloroorcinol 0.63 29.1
6 Control 0 34.2
ext.
' J  J  —
-> Unknown
• & $   * Origin
. 1
i i
1 2
kig. 3.18 Autoradiogram showing the influence of
(cf. p.129) 3,5-dichloroorsellinic acid (DCOA) on 
resuspended mycelium of P.cyclopium.
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Table 3.8 Influence of 5- chloroorsellinic acid on mycelial
growth and penicillic acid production (addition to cultures
at the time of inoculation) . cf. p.124
aConcn.
Mx10~4
Mycelial 
mg/flask
b.
wt.
% growth
Penicillic acid 
%  control
0 931 100 100
2.5 975 105 100
5.0 1013 108 100
9.9 1040 112 90
Table 3.9 Influence of orsellinic acid on mycelial growth and 
penicillic acid production (addition to culture at the 
time of inoculation)* cf. p. 124
For both tables a = initial concentration of orsellinic acid
or its 5-chloro derivative.
b = Mycelia harvested after 7 days' growth.
CHC1.-, Penicillic
b benolic Gone. Mycelial wt. extract acidc
Q. 1 Ampound (Mx10 ) (mg /flask) % growth (mg./flask) (% control)
Resor- 0 960 100 79.0 100
ylic 5.4 910 94 71 .2 90
cid 10.8 806 84 67.1 80
0 985 100 81.0 100
esorci- 7.5 945 96 81 .8 100
ol 15 827 84 61.7 80
rcinol 0 864 100 90/7 : 100
13.4 823 95 86.5 90
rcinol- 0 864 100 90.7 100
ono- _ 6.2 879 102 52.6 50
ethyl 12.4 860 100 8.9 5
ether
3,5-di-
0 1097 100 71 .3 100
1.3 790 72 69.3 100
bromoor-
2.6 641 58 ■ 16.3 20
sellmic
OJ • 00 481 44 7.6 5acid
5.1 30 3 6.5 0
le 3.10 'Influence of some phenolic compounds on mycelial growth and 
. p.128) penicillic acid production.
(a) Addition to spore-inoculated submerged culture after 
24hr. growth.
(b) Cultures were harvested 7 days after inoculation.
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3.2.4 Experimental
3.2.4 Experimental
3.2.4.1 Preparation and Inoculation of the Solid Medium (PDA)
The solid medium contained potato extract (prepared by 
boiling potato slices (200g) in water (1.01) for 45 mins.),
2 % glucose, and 2% agar. Portions of hot medium (10ml) were 
poured into the culture tubes and autoclaved (at 15 lbs/sq.in. 
pressure for 15 mins.). The culture tubes were then allowed
to cool on a sloped surface.
Previously prepared slopes were inoculated from a sporing
slope of P .cyclopium (IMI, 89372, obtained from the Common­
wealth Mycological Institute, Kew, Surrey) by the transfer 
of spores on a wire in sterile surroundings; slopes were then 
incubated in a stationary incubator for seven days at 24°C.
3.2.4.2 Preparation and Inoculation of the Liquid Media
Composition of the media are as follows:
I) Raulin Thom medium; D(+)-glucose (anhydrous,50g) , 
tartaric acid (2.67g), ammonium tartrate (2.67g), magnesium 
carbonate (0.27g), zinc sulphate (hepta-hydrate, 0.047g), 
ferrous sulphate (hepta-hydrate, 0.047g), ammonium sulphate 
(0.17g), potassium carbonate (0.4g), and diammonium hydrogen 
phosphate (0.4g) are dissolved in distilled water (11) .
The initial pH of the medium is 4.0.
II) Czapek-Dox Medium; D(+)-glucose (anhydrous, 50g), 
sodium nitrate (2.0g), potassium chloride (0.5g), magnesium 
sulphate (hepta-dydrate, 0.5g), ferrous sulphate (hepta- 
hydrate, 0.01g) and potassium dihydrogen phosphate (l.Og) are 
dissolved in distilled water (1.01). The initial pH of the 
medium i.s 6.
In either case, 350ml and 60ml of media were placed 
into 11, and 250ml conical flasks respectively. The flasks 
were then plugged with non-absorbent cotton and sterilised 
by autoclaving at 15 lbs/sq.in. pressure for 20 minutes.
The big flasks were provided for surface, and small flasks 
for submerged cultures.
Sterile solution of Tween 80 (0.01%, 10ml) was poured 
into a heavily sporing slope and the surface of the slope 
was scratched with a wire. An aliquot (3ml) of the spore 
suspension was then poured into the 11 flasks under sterile 
conditions and kept in a stationary incubator at 24°C. An 
aliquot (1ml) of the spore suspension was used for submerged 
cultures and kept in an orbital incubator (240 r.p.m.) at 24°C.
Large variations in mycelial growth were observed in the 
submerged cultures. The following method was therefore usdcl 
for inoculation; a submerged culture was prepared in the 
same way as the above cultures. After 30 hrs. of growth,
2ml of the mixed young mycelium and media was .used for ino­
culation of a new flask.
3.2.4.3 Course of. Fermentation of P.cyclopium
Submerged cultures were harvested in varying time of 
L.incuiation between 1 and 8 days, and the following measure­
ments were carried out (the same procedure was followed for 
surface cultures . harvested in the range of 3 to 15 days 
growth);
I) Mycelial weight
Mycelium was pressed dry on a Buchner funnel and then 
dried in a vacuum desiccator over fresh phosphorus pentoxide 
for 2 days.
II) Measuring of pH
The pH of the culture filtrates was determined using 
an E.I.L.-23A pH meter, against standard buffers of pH 4 
at 20°C.
III) Measuring of glucose
Glucose concentration of the filtrates was determined 
by the following methods:
a) Spectrophetometric method - the technique is based on 
enzymatic oxidation of glucose to gluconate. In this re­
action, the hydrogen peroxide obtained is treated with 
diammonium1 2,2’- azino-bis (3-ethylbenzothiazoline-6-sulfonate) 
to give a coloured complex .
In practice, a standard solution (0.1ml) of glucose 
(0.455mg /100ml ) was placed in a test tube, and a mixture 
of phosphate buffer, enzyme and chromogen (5ml, pH =  7) was 
then added. The reaction mixture was kept in a water bath
(37°C) for 15 minutes, and an aqueous solution of H^SO^
(20%, 2ml) was then added with shaking the mixture. The
optical density of this solution was measured in varying
wavelengths ranging from 370-600nm. Each time the absor-
bency of the blank solution was adjusted at zero (this
solution contained the standard contents except glucose;
and the volume was made up with adding water (0.1mi). The
typical spectrum is shown in Fig. 3.19 (p.-1'47). According
to this experiment A of the reaction mixture was foundmax
to stand at 435nm. This wavelength was used for measuring 
a series of standards and samples of glucose. The calibra­
tion curve is shown in Fig. 3.20 (p. 147).
b) In this method rotation (ex.) of polarised sodium light 
in diluted metabolism solutions (5ml of 5 times diluted 
filtrates) was measured by a polarimeter. A related concen­
tration of glucose was obtained from a calibration curve of 
the glucose standards ranging from 0.2 to 1.0g/100ml. Since 
some of the metabolism solutions were heavily coloured as 
well as having a low glucose content, this method was not 
considered successful for these studies.
(IV) Chloroform extracts of the filtrate - the efficiency 
of extraction of the fungal metabolites from Raulin-Thom 
medium was determined as follows:
Amount of the fungal metabolites added to 60ml
of Raulin Thom medium 61.2mg.
pH of the medium 2
Volume of chloroform used for first extraction 40ml,
Volume of chloroform used for second extraction 40ml
Weight of the residual of the first extraction 51.6mg
Weight of the residual of the second extraction 4.?mg.
Total of the fungal metabolites extracted 56.3mg
The efficiency of extraction 36.3x100 - 92%
61.2
3.2.4.4 Detection of the Metabolites
Standard technique of thin-layer chromatography on 
silica gel OF 254 (0.25mm thick) was used for a preliminary 
detection of the metabolites in chloroform extracts of 
culture filtrates (at pH 2) and acetone extract of mycelium. 
This was carried out by using different solvent systems 
such as:
A) organic phase of the mixture of CHCl^;CH^0H;Ho0;HC00H
5 5 ^
(250:24:25:1 v/v)^^
B) mixture of OHCl^jCH^COOEt;HC00H (60:40:1 v/v)162
C) mixture of CHCl,;C2H50H (19:1 v/v)
The following instruments were used for analysis of the
metabolites:
Uv - spectrophotometer, Unicam Sp-8000.
Ir - spectrophotometer, Perkin-Elmer 157G-.
Nmr - spectrometer, Perkin-Elmer R-24A.
Mass spectrometer MS-12.
3.2.4.5 Isolation of the Metabolites
This was carried out by preparative chromatography 
using silica gel plate (1mm thickened). The zones which 
appeared on preparative chromatogram were eluated as follows;
The zone scraped was placed in a small column (1 x 20 cm) 
and the metabolite eluated with a flow of methanol (10ml).
The collected solution was then evaporated under a reduced 
pressure to dryness residue, and it used for further inves­
tigations .
Penicillic acid:
Since uv-spectrum of penicillic acid in ethanol gives 
a distinguishable peak at 225nm, the following method was 
used for estimation of this acid;
Chloroform extracted residue of the filtrate was dis­
solved in ethanol and its absorbency measured against ethanol 
(as blank) at 225nm. The corresponding concentration was 
then obtained from calibration curve (Pig. 3.23 appendix).
-  1^ 0 “
Isolation of penicillic acid was carried out from 
11 days old surface and 7 days old submerged cultures of 
P. cyclopiurn on Raulin-Thom. In these cases the combined 
chloroform extracts of the metabolism solution was evaporated 
under reduced pressure, and the residue, recrystallised from 
chloroform-cyclohexane mixture (1:3). Penicillic acid ob­
tained as a white crystalline solid m.p.83-84°C.
Orsellinic acid:
The orsellinic acid zone on preparative t.l.c (chlo­
roform extracted residue of 3 days old submerged culture) 
was scraped and eluated with methanol. Optical density of 
this solution was then measured at 254-nm , and the corres­
ponding concentration was deduced from calibration curve 
(Fig. 3.21 ,p.148) of orsellinic aci-d.
3-methoxy-2,3-toluoquinol and 3-methoxy-2,5-toluquinone:
These compounds were also detected in the chloroform 
extracted residue of submerged cultures (3 days old) on t.l.c. 
plate using solvent A. The metabolites were isolated by 
preparative thin-layer chromatography similar to the above 
method. 3-methoxy-2,5-toluquinol was -crystallised from cold 
carbon tetrachloride (white crystals, m.p. 131-132°C litj^ 
130-131°C). The crystallization of 3-methoxy~2,5-toluquinone 
in the same solvent yielded yellow needle form crystals 
(m.p. 155-156°C, lit.119 155-156°C).
3.2.4.6 Course of fermentation of P.cyclopium in the presence
of potential inhibitors.
In these experiments the inhibitor was added after 30 hrs. 
to P2 second stage) submerged cultures. The cultures
were obtained following inoculation with an initial culture 
previously grown for 30 hrs. The sumberged cultures were 
harvested after a total growth period of 7 days. Por trial 
experiments the feeding compounds were added to P^ cultures 
at the time of inoculation and also 24 hrs. old cultures.
3.2.4.7 Autoradiographic studies
a) Control culture; the fresh mycelium (1g ) was incubated
*1 A-
with [1- C ] -sodium acetate (5 j^Ci) in sterile water (2ml) 
for 16 hrs. The culture was then harvested and the filtrate 
extracted with two 4ml-portions of chloroform (at pH 2).
The combined chloroform extract was evaporated under reduced 
pressure, and the residue obtained used for providing a thin- 
layer chromatogram. An X-ray film (Kodak; cat. No. 3056207) 
was exposed with a thin-layer chromatogram for 48 hrs., and 
then developed.
b) In the presence of potential inhibitors; the above proce­
dure was repeated when the myqelium was incubated in different 
concentrations of potential inhibitors.
The X-ray films were processed by a standard procedure
1 A
using recommended solutions for developing and fixing.
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